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Lumbosacral stenosis (LS) is a structural narrowing of the spinal canal in the canine 
lumbosacral spine.  Large-sized working and sporting dog breeds such as Labrador 
retrievers are predisposed for reasons that are incompletely understood.  The narrowing 
of spinal canal observed in LS can cause compression of underlying meningeal, neural 
and vascular tissues, which in turn can lead to clinical symptoms like lower back pain, 
incontinence and in severe cases loss of function in the lower limbs.  The standard 
criteria for clinical diagnosis of this condition include a painful reaction to palpation of 
lumbosacral spine region, inability or unwillingness to raise the tail and/or reluctance to 
perform certain tasks that involve either the stretching of or stress on the lumbosacral 
joint.  However, working and sporting breed dogs are bred to be highly stoic, 
cooperative, driven, and task focused.  These behavioral traits make clinical detection of 
LS difficult in the early stages. Dogs with LS may continue to work, develop 
compensatory gaits, and experience repeated LS injury.   By the time a diagnosis of LS 
is confirmed, oftentimes it is too late for successful therapeutic intervention and the only 
course of action left for improving the dog’s quality of life is either retirement from active 
duty, or in severe cases euthanasia. Therefore early diagnosis is essential for 
maximizing the quality of life, and minimizing the likelihood of early retirement in working 
dogs. Lumbosacral stenosis is usually considered to be a condition associated with 
degenerative changes observed with normal aging, however presence of the disease in 
young and middle aged working dogs has also been reported. This leads to the 
probable theory that some dogs in large breeds like Labrador retrievers might be 






Radiographic screening is common practice for agencies that purchase, train, and use 
working dogs. Dogs with morphologic traits such as canine hip dysplasia, canine elbow 
dysplasia, and transitional lumbosacral vertebrae are commonly rejected. However 
radiographs are insensitive for detecting LS. Advanced imaging methods such as 
computed tomography (CT) and magnetic resonance imaging (MRI) and the current 
standard diagnostic tests for detection of LS. These modalities are considered to be 
complimentary, with each offering different strengths for visualization of bony and soft 
tissue structures.  For working dogs, computed tomography offers advantages of 
greater availability and the faster scanning times that allow the use of reversible 
sedation.  Qualitative CT phenotyping is a standard method for clinical diagnosis of LS 
in dogs. However, for research purposes, a method for quantitative phenotyping of LS 
would also be beneficial. There is a lack of published evidence for a consensus on any 
such quantitative CT phenotypic traits in humans or dogs. In the first study, we 
developed one such quantitative trait using CT imaging in a sample of 25 Labrador 
retrievers – fat area ratio or FAR (ratio of the vertebral canal fat area content in a 
transverse slice to the vertebral body area in the same transverse slice). This 
measurement was found to have good agreement with the standard qualitative 
assessment of LS (as made by a certified veterinary radiologist); and we propose that 
FAR can be used to quantify LS especially in a research capacity. 
 
Lumbar spinal stenosis (LSS) is a human condition that is often considered to be 
orthologous to canine LS. Genetic studies in humans have shown promise in 
identification of possible genetic factors that might be associated with LSS. The 
predominant genetic approach for research in canine LS has been pedigree analysis 
especially in the German shepherds; but no genetic association studies have been 
reported in any breed.  The second study of the project was an attempt at the 
investigation into the genetic characteristics of LS in Labrador retrievers. To do so we 
analyzed the exome of 8 young Labrador retrievers – 4 positive for LS and 4 negative 
for LS, from a pool of 40 Labrador retrievers in the US military working dog (MWD) 






used for quantitative phenotyping of the 40 dogs (as well as qualitative CT 
phenotyping); followed by the selection of 8 dogs best representing the extremes of the 
phenotype – LS affected and LS unaffected. We were able to identify 3 genes – TTR 
(Transthyretin), FOLR2 (Folate Receptor 2) and USP9X (Ubiquitin Specific Peptidase 9, 
X-linked) – that could possibly be associated with canine LS. However, follow-up 
analysis is necessary to determine the true nature of the relationship between these 
genes and LS in Labrador retrievers. These 3 genes could potentially be new 
“candidate genes” for canine LS – not just in Labrador retrievers but also in other 
affected breeds. Further studies are also needed to investigate the role of these 
candidate genes in human LSS.  The inability of LS in getting detected by simple 
radiographs is a major disadvantage for the agencies that procure, train and employ 
working dogs like the military and transportation safety authority. This necessitates the 
identification of genetic marker/s of LS that could then possibly be developed into 
simple diagnostic tests. And if certain breeds are indeed genetically predisposed, these 
diagnostic tests could perhaps even become standard screening protocol during the 
acquisition of these dogs. Labrador retrievers are loyal, kind, and intelligent breed of 
dogs; with greatly versatile applications beneficial to humans. Even though other breeds 
are used as working dogs around the world, Labrador retrievers cannot be easily 
replaced and the demand for this breed has been steadily increasing over the past 
decade. A possible genetic test that can identify genetic predisposition to LS in young 
Labrador retrievers that might become working dogs can significantly improve the 
procurement process. And if reasons behind early occurrence of LS were premature 
degenerative changes instead, early detection would mean preventative conditioning 
training protocols and better therapeutic treatments.  However, it is important to note 
that LS is not restricted to working dogs (young and old) alone, the disease also 
appears in non-working dogs (more commonly in older dogs). But, early detection of LS 
would improve the quality of life of Labrador retrievers – both working and non-working 
that might be affected by LS. It would also be beneficial for the agencies that employ 
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CHAPTER I. INTRODUCTION 
 
Working dogs are high-performance athletes and vital members of teams that support 
public service, national security and military missions in the U.S. and around the world 
1. The job titles of working dogs are varied and include, but are not limited to: guide 
dogs (for the disabled like the blind and the deaf); service dogs (for individuals with 
medical conditions that range from epilepsy to diabetes); assistance and therapy dogs 
(for individuals with physical disabilities and post-traumatic stress disorder as seen in 
war veterans); detection dogs (explosives, arson accelerants, illegal drugs, agricultural 
pathogens, pirated DVDs and other contraband, for the Transportation Security 
Administration, the police, and the military); and search and rescue dogs (natural or 
man-made disasters). The list of ways in which dogs are trained to perform currently 
(and could potentially be trained to in the future) are both varied and numerous. German 
shepherds, Labrador retrievers, and Belgian Malinois are the most commonly used 
breeds 2 and; since 9/11, the demand for working dogs has only increased dramatically 
3.  
 
One such in-demand population of working dogs is the military working dog (MWD). 
Military forces worldwide recognize MWDs as “force multipliers”. An American Forces 
Press Service release (October, 2015) estimated the US military to have around 2,300 
MWDs (http://usmilitary.about.com/od/jointservices/a/militarydogs.htm). The dogs 
represent all branches of the military, and together with their handlers they are deployed 
worldwide to serve American interests. According to a 2011 US Government Pentagon 
memo, typical purchasing and training costs for a high quality military working dog can 
range anywhere from $20,000 to $40,000 (depending on the nature of their 
assignments, and whether or not the dog is trained for multiple types of tasks) 
(http://www.nytimes.com/2011/05/12/world/middleeast/12dog.html?_r&_r=0). Once they 
are trained, the service lifetime of a typical MWD is expected to average about 10–12 
years (http://todaysmilitary.com/videos/a-military-working-dog-handler).  However this 




trauma 2.  Premature loss of active duty capability in a trained MWD causes not only a 
major financial loss to the US Military, but also a functional loss for the productivity of 
the team that depends on the particular dog. Team readiness remains reduced until 
they can purchase and train a new dog.  As the worldwide competition for high quality 
dogs increases; so does the cost of breeding, raising and subsequent training of the 
dogs, as a result of which, the availability of new dogs also decreases. Therefore, 
ideally teams need to have dogs that can maintain functionality for as long as possible.  
 
Lumbosacral stenosis (LS) is the most common pathological condition affecting the 
canine lumbosacral spine 4 5 6. Lumbosacral stenosis is defined as an abnormal 
narrowing of the lumbosacral canal, vertebral canal, and/or the intervertebral foramina 
between the L5-S3 vertebral segments leads to the compression of the underlying 
neural and vascular tissues 7 8. This structural “narrowing” can lead to clinical conditions 
like cauda equina syndrome (CES). Degenerative LS is the most commonly reported 
etiology that is believed to be associated with aging; similar to the orthologous human 
condition known as lumbar spinal stenosis (LSS). However, some studies suggest LS 
might have a genetic predisposition that can manifest itself at an early age 9 10 11. This 
predisposition has been predominantly accounted for by the congenital anomaly of 
lumbosacral transitional vertebra (LTV) – an abnormally formed vertebra usually 
between the last lumbar and first sacral vertebra 12 13. The presence of LTV often leads 
to abnormally narrow spinal canal (lumbosacral stenosis); which in turn can lead to 
clinical conditions like CES. Congenital version of LS is rare, but the causes can be 
either developmental (achondroplasia related) or idiopathic (reasons unknown).  
 
The larger sized breeds like German shepherds, Labrador retrievers and Golden 
retrievers that are the popular choice for working dogs also happen to have a higher 
than normal incidence of LS. Scientific research of canine LS has leaned heavily on the 
German shepherds breed, both due to high number of reported cases as well as their 
popularity as working dogs. However in recent years the popularity of the Labrador 




due to their excellent scent detection skills, high drive, eager-to-please attitude and 
ease of trainability 14 3. Labrador retrievers are also the most popular household pet 
breed in the United States, and have been so for the past twenty-five years in a row 15. 
Unfortunately the very characteristics that make this breed such great working dogs; 
also make it difficult to detect LS. Working Labrador retrievers are excellent at masking 
their pain and discomfort to continue pleasing their people/handlers/owners. The 
degenerative/progressive nature of the disease can be extremely harmful if 
detection/management is delayed. Currently CT/MRI imaging methods are the only way 
of detecting the structural abnormality of stenosis or “narrowing”. However, unless a dog 
presents with some clinical signs of pain or discomfort, expensive imaging studies are 
not performed in “suspicion” of an underlying condition like lumbosacral stenosis; and 
the condition can go undetected longer often exacerbating the condition. Therapeutic 
interventions are more effective in young dogs with mild stage clinical conditions, with 
relatively successful return to active life, thus the need for early detection 16. The 
procurement, training and ultimately the deployment of the working dogs to their theater 
of duty is an extensive process that involves significant investment of time, money and 
other valuable resources. An improved understanding of the genetic mechanisms 
underlying LS would be highly beneficial – not only for better therapeutics but also for 
better diagnostics.  
 
Findings from canine LS studies in Labrador retrievers could also be applicable to other 
dog breeds (and possibly humans too due to the pathophysiological similarity between 
canine LS and human LSS). Lumbar spinal stenosis is defined as “any type of 
narrowing of the spinal canal, nerve root canals or intervertebral foramina” that leads to 
neurogenic claudication 17. Degenerative LSS is the most commonly reported type of 
human LSS affecting individuals older than 65 18 19. However aging is not the sole 
contributing factor for this structural abnormality, even though rare LSS has also been 
observed in younger individuals. The most common type of congenital LSS is usually 
associated with dwarfism related genetic disorders (supporting the theory that LSS is a 




understand the underlying genetic mechanism of LSS. They have been able to identify 
some genetic polymorphisms that appear to be associated with the presentation of LSS 
20 21. In the United States alone, there is an estimated 400,000 individuals affected with 
LSS 22. Decompressive surgery to correct LSS has become the most common spinal 
surgical procedure in recent times 23. Similar to the canine version, LSS is not life 
threatening but it does significantly diminish the quality of life due to substantial 
disability, limiting the ability to perform routine daily life activities. Currently there is no 
cure for LSS in humans or LS in dogs, only ways of managing the symptoms to improve 
the quality of life 24 25 22. The genetic similarities between the two species – human and 





CHAPTER II. LITERATURE REVIEW 
Lumbar Spinal Stenosis 
Anatomy of the normal lumbar spine  
The spinal canal is delineated by the vertebrae, discs and the posterior longitudinal 
ligament anteriorly; pedicles, the ligamentum flavum and the neuro-foraminae laterally; 
and laminae, facet joints and the ligamentum flavum posteriorly. The normal shape of 
the human lumbar spinal canal can be circular, elliptical/oval or trefoil (rounded triangle) 
26 27. There is a gradual change from a more circular to a more triangular shape 
(narrowing trend) as the spine transitions from thoracic to sacral region. The trefoil 
shape of the spinal canal usually appears in the fifth lumbar vertebrae. The antero-
posterior (AP) diameter of the lumbar spinal canal usually decreases from L1 to L3 and 
increases from L3 to L5, so it is at its narrowest at the third lumbar vertebrae 28 29 30. 
There is a small increase in the transverse diameter from L1 to L3, after which (L3 to 
L5) there is a simultaneous increase corresponding to the increase in AP diameter. 
Cross-sectional areas decrease from L1 to L2, remains somewhat constant in L2 to L4, 
followed by an increase at L5. The consistent increase in the cross-sectional area of the 
lower spine from all angles seems to be present to accommodate the neural tissue of 
the cauda equina. Cauda equina, which literally translates to “horse’s tail”, is the bundle 
of all the spinal nerves and nerve roots that originate throughout the spine (2nd to 5th 
lumbar, 1st to 5th sacral and the single coccygeal) but emerge only from the conus 
medullaris (termination point of the spinal cord).  
 
Etiology and pathogenesis  
The amount of space available to the nervous tissue inside the spinal canal is decided 
by a combination of two factors: morphogenesis and development of the spine during 
gestation and the early developmental years; and the degenerative changes that occur 
to the spine over the course of time. The lumbar vertebrae begin to form after the 




begin to develop 31. These arches then start to ossify and meet at the centrum – the 
union being the first defining event to decide the dimensions of the neural canal (even 
though the canal does not finish forming until several years after birth) 32. Any kind of 
error during this stage can result in a narrowed spinal canal, which can remain clinically 
asymptomatic until other confounding factors give rise to a clinical condition. The 
stenotic canal usually presents with a narrower inter-pediculate diameter 33. Both the 
pedicles and lamina appear to be shorter and thicker 34. The facets also become 
enlarged and bulbous, nearly coming in contact with the spinous processes. This 
abnormal narrowing of the spinal canal, nerve root canals and/or intervertebral foramen 
leading to compression of the inner neural tissue is defined as spinal stenosis 17.  
 
Arnoldi classified lumbar spinal stenosis into three types based on anatomy – central 
canal stenosis (bordered by vertebral bodies, discs, and articular processes); lateral 
recess stenosis (sub-articular canal extending from the thecal sac to the pedicle); and 
foraminal stenosis (intervertebral foramen or nerve root canal present under the pedicle) 
17. The causes that result in the different forms of stenosis are as follows: 1) central 
canal stenosis from hypertrophy of the interlaminar portion of the ligamentum flavum, or 
disc protrusion/herniation; 2) lateral recess stenosis from degeneration of the ligaments 
and/or facets, disc herniations, posterolateral disc protrusion, or superior articular 
process hypertrophy; and; 3) foraminal stenosis from bone “spur” formations 
(osteophytes), facet joint hypertrophy (osteoarthrosis), or tissue hypertrophy due to 
spondylolisthesis.  
 
Arnoldi (1976) classified lumbar stenosis into three types based on etiology – 
congenital, acquired, or a combination of both. First reported in children by Sarpyener 
(1945) 35, the congenital form can be further divided into two categories – idiopathic and 
achondroplastic. The idiopathic form is extremely rare and only a few cases have been 
reported to date. The achondroplastic form is slightly more common and is associated 
with dwarfism related disorders 36. However, recent studies have reported congenital 




cervical form being more common in younger individuals than the lumbar form 39. 
Verbiest (1954) was the first to observe acquired stenosis in adults. This form of 
stenosis has proved to be the most prevalent type and is usually known to present itself 
in individuals older than 65 18. This delayed appearance of stenosis is believed to be 
due to the association of spinal stenosis with aging. It may often take up to the fifth 
decade of life for the degenerative effects of aging to accumulate and manifest itself 
with initial clinical signs. Commonly observed degenerative changes associated with 
LSS are disc degeneration, facet joint osteoarthritis, ligament hypertrophy, spondylosis, 
spondylolisthesis, and/or osteophytes 40. Acquired stenosis can also be a result of 
surgical 41 or traumatic conditions 42, like – diffuse idiopathic skeletal hyperostosis 43, 
Paget’s disease 44, ankylosing spondylitis 45 46, or rheumatoid arthritis 47. Metabolic 
diseases like acromegaly 48 49, hypoparathyroidism 50, pseudohypoparathyroidism 51, or 
X-linked hypophosphatemic osteomalacia 52 can also cause lumbar spinal stenosis. 
Ciricillo and Weinstein (1993) have listed the known causes of spinal stenosis in their 
review paper (Table II.1) 53. 
 
Clinical presentation  
The first ever mention of lumbar spinal stenosis related symptoms was in Greek 
mythology – the God Hephaestus was achondroplastic, and after a trauma to the 
narrow spinal canal developed a limp, which in turn led him to being mocked by the 
Olympians 54. Mythological references aside, the French physician Antoine Portal was 
the first to correlate low back pain (LBP) with narrowing of the spinal canal 55. However 
until the 1950’s, the primary cause for LBP was believed to be solely disc-related 56 and 
spinal stenosis as a cause for LBP went mostly uninvestigated. Dutch neurosurgeon 
Hank Verbiest was the first to coin the term “spinal stenosis” in his landmark 1954 
publication 57. Even though LBP is the symptom most commonly associated with spinal 
stenosis, it is not the defining symptom for diagnosis of the disorder – clinical symptoms 
can be highly variable.  The current standard clinical symptom for a confirmed diagnosis 
of LSS is neurogenic claudication – described as the presence of weakness, tiredness, 




usually go away on resting 58 59 17 60. However, there exists a lack of consensus 
regarding the true constitution of the clinical symptoms that arise due to LSS, making 
diagnosis difficult 61. However, there exists a lack of consensus regarding the true 
constitution of the clinical symptoms that arise due to LSS, making diagnosis difficult 61.  
 
The physiological explanation of the symptom of intermittent neurogenic claudication is 
made up of the combination of two theories – neurogenic compression theory and 
vascular compression theory 62 60 63. The neurological dysfunction can be explained by 
the neurogenic compression theory. As seen in animal models, if there is mechanical 
stimulation after prolonged compression of neural tissue, an abnormal electrical 
discharge happens that presents itself as pain. Compression of neural tissue actually 
means decreased supply of cerebrospinal fluid and other nutritional substances to the 
nervous tissue, which in turn causes edema, build-up of noxious substances and 
fibrosis due to microvascular changes. The intermittent aspect of the functional 
dysfunction can be explained by vascular compression theory. According to this theory, 
the increased pressure inside the spinal canal is not only on the neural tissue but also 
on the blood vessels that supply the neural tissue. When active or in motion, the 
compressed blood supply is not sufficient for proper functioning of the neural tissue, 
causing pain. When in rest, the canal widens, blood supply becomes sufficient enough 
and the pain goes away. But both the theories cannot explain how some patients with 
severe stenosis can still remain asymptomatic. Other symptoms include mechanical 
low-back pain that worsens during activity, atypical non-radicular leg pain, pain in the 
buttocks and on rare cases cauda equina syndrome 56 64. Cauda equina syndrome may 
include associated symptoms of urinary and bowel incontinence. 
 
With regards to the localization of symptoms, the pain is bilateral and poorly localized in 
central canal stenosis, while in lateral canal stenosis the pain is more localized to one or 
few nerve roots 53. Multi-level neural tissue compression has also been associated with 
neurogenic claudication in cauda equina syndrome 65 62 60. However, it should be noted 




with the severity of clinical symptoms displayed. Some studies suggest that males are 
affected by LSS more than females 66 67 53; however contradictory reports have also 
been published where any one sex has not proved to be more affected by LSS than the 
other 19. 
 
Clinical diagnosis and diagnostic imaging  
Congenital forms of stenosis, though rare, are easily diagnosable by radiographs 68. The 
acquired form of stenosis is slightly more deceptive. Even though a chronic condition, 
the symptoms of LSS can often develop insidiously with sudden onset. Clinical 
examination can also be misleading, but once detected, like similar spinal disorders, a 
thorough neurological examination is mandatory protocol 69. The non-specific symptoms 
include limited lumbar extension, sensory deficit, muscle weakness, straight-leg raising, 
and missing knee and ankle reflexes. The intermittent as well as the sometimes-
asymptomatic nature of the symptoms like neurogenic claudication can often lead to 
delayed diagnosis. Thus, the only way to confirm a positive diagnosis of LSS is through 
diagnostic imaging studies 70 71. Each confirmed case of LSS by imaging can be further 
graded as mild, moderate or severe; but this grading is subjective and can be another 
cause of misdiagnosis.  
 
The two most common diagnostic tests for LSS in human and LS in dogs are computed 
tomography (CT) and magnetic resonance imaging (MRI). These methods are often 
considered to be complementary to each other. The most striking difference between 
the CT and MRI is that denser tissue appears brighter and whiter in CT, while denser 
tissues appear darker and blacker in MRI. Computed tomography works on the principle 
of electromagnetic energy attenuation – x-ray photons penetrate the body and based on 
the density of the target tissue, some of the energy gets absorbed and the rest exits the 
body slightly attenuated. The residual energy that escapes the body gets registered on 
a photon detector which when developed, reflects the difference in tissue densities 
depicted in shades of grey. MRI is also an emission-based technology that takes 




emit radiofrequency signals in the presence of opposing magnetic fields and start 
resonating. This resonance is detected and recorded in the form of grey-scale images.  
 
Computed tomography uses a hollow x-ray tube that rotates around a stationary patient 
table, emitting x-rays that pass through and get captured as a series of x-ray projections 
on detector films, producing cross-sectional anatomical images that distinguish between 
tissues based on density differences 72 73. Computed tomography can capture images 
from multiple panes, and give a detailed and precise three-dimensional visual for the 
bone and soft tissue structures inside the body (after multiplanar reconstruction) 74 75. 
The ability of CT lies to capture images in the trans-axial plane makes it the preferred 
imaging method for the detection of LSS 76. Computed tomography also allows 
evaluation of the shape of the canal, and making accurate measurements of the bony 
spinal canal dimensions directly from the images. Computed tomography has good 
contrast resolution (differentiating between bony and soft tissue) and can directly view 
the effects of disk pathology, facet hypertrophy, and thickened ligamentum flavum on 
the cross-sectional area of the canal 77. However, the soft tissue resolution of CT is not 
as great as that of MRI – making it difficult to detect nerve root compression and other 
soft tissue pathologies. It is possible to overcome this disadvantage of poor soft tissue 
resolution by detecting changes in adjoining tissues (dural sac and epidural fat) for 
diagnosis of LSS 78. Therefore, CT is the considered to be an optimum imaging 
technique for the overall diagnosis of LSS –balanced detection capability of changes in 
both bony and soft tissue. Spinal canal area measurements made by CT often do not 
agree with measurements made by MRI often in the same samples, theorized to be due 
to the superior delineation of the ligamentum flavum by CT 79. Computed tomography is 
also better at visualizing zygapophyseal joints 80 and differentiating between hard 
versus soft disc pathology 81. 
 
Qualitative and quantitative computed tomography characteristics  
The application of CT to spinal imaging began in the 1970s and has since then provided 




and compression of the emerging nerve root) 82 83 84 71. McAfee and Ullrich (1982) 
described the normal anatomy of the lumbar spine, using the 5th lumbar vertebra as an 
example, as observed in 3 successive trans-axial CT images (increments of 1.5 mm): 
First slice: nerve roots lie in an unresolved bunch within the lateral recesses of the 
vertebra at the lower edge of the pedicles, and epidural fat remains distributed around 
the thecal sac in a symmetrical manner. Second slice: nerve roots exit through the 
upper portion of the neural foramina that lies immediately beneath the lower margin of 
the pedicles, the ligamentum flavum appears as a V-shaped soft tissue behind the 
thecal sac, the anterior extensions of which join the medial portions of the facet joint 
capsules. Third slice: nerve roots become part of the paraspinal structures after its exit 
from the neural foramina and the posterior longitudinal ligament remains 
indistinguishably adjacent to the annulus fibrosis.  
 
A stenotic canal appears distinctly different from the normal canal in a CT image 70 83. 
Qualitative characteristics of LSS visible in CT images include: bulging discs, 
osteophytes along the vertebral margin, spondylolisthesis, thickened pedicles, spinous 
and transverse processes, thickened ligamentum flavum, facet joint capsule 
hypertrophy and subluxation, and/or degeneration of the discs 71. These bony and soft 
tissue abnormalities can be both causes of LSS, as well as symptoms and side effects 
of LSS. This in turn leads to difficulty in identification of the actual cause of stenosis in 
an individual once the symptoms start progressing. Since the visible structural 
abnormalities usually present themselves in combinations of each other, separating one 
from the rest can be difficult 77 75 85.  
 
Even though LSS is defined as “narrowing”, there are very few evidence-based reports 
where the “stenotic” vertebral canal dimensions have been defined, or compared with 
“normal” canal dimensions 86. Radiological measurements for a stenotic canal were the 
first to be proposed 87 but their accuracy was questionable due to two reasons: (i) they 
were static measurements and did not account for the dynamic nature of the condition; 




choice as it allows for exact measurements of the spinal canal while also taking into 
account that LSS is a dynamic and multi-level condition 62 65. This is possible because 
CT also allows for images to be collected from symmetric axial sections perpendicular 
to the anterior bony wall of the vertebral canal 88 89. McAfee and Ullrich (1982) 
described their quantitative criteria for diagnosing LSS using 3 numerical 
measurements: (1) antero-posterior (AP) diameter; (2) inter-pediculate distance; and (3) 
cross-sectional area; and a canal was assigned LSS positive if either the antero-
posterior diameter was less than 11.5 mm, and/or inter-pediculate distance was less 
than 16 mm, and/or cross-sectional area was less than 1.45 cm2 75. Schonstrom (1985) 
defined the threshold for a ”stenotic” canal as a cross-sectional area of 0.85 cm2 83; and 
Zheng (2006) assigned a cross-sectional area threshold value of 1.4 cm2 90. Verbiest 
(1954) defined a canal as “stenotic” when the sagittal diameter was less than 10 mm. Of 
the three measurements described by Ullrich (1982): AP diameter, inter-pediculate 
distance and cross-sectional area – the cross-sectional area measurement is 
considered to be the most sensitive for diagnosis of central canal stenosis since it 
integrates the entire bony ring that forms the canal and is more likely to detect 
asymmetrical canal narrowing or lateral canal narrowing 77 85 83 91 92.  
 
Genetic characteristics  
The congenital form of stenosis is typically associated with achondroplastic disorders, 
which are genetic disorders by nature 36 93. So it has long been suspected that other 
types of LSS might also be influenced by genetic factors. Some early familial studies of 
LSS in siblings have also pointed towards a genetic connection 94 95 96.  
 
Ossification of posterior longitudinal ligament (OPLL) is a pathology that can often lead 
to LSS and has a higher than normal incidence in the Japanese population 97. This 
genetic predisposition in a geographically distinct population also supports the theory 
that LSS is influenced by genetic factors. Both Postacchini (1985) and Yoshida (1992) 
have discussed the importance of collagen fibers in the disease process of LSS 98 99. 




that also contains the gene COL11A2 100. Lumbar disc disease (LDD) is another 
pathology that is believed to be a leading cause of LSS. Tryptophan alleles in COL9A2 
(Trp 2) 101 and COL9A3 (Trp 3) 102 have shown an association with LDD in the Finnish 
population. A study done in mice to study age-related spine degeneration, identified a 
heterozygous mutation that causes haplo-insufficiency of the aggrecan gene (AGC1) 
and results in intervertebral disc herniation and degeneration 103. This finding in mice 
was later repeated in humans along with identification of an association between a 
VNTR in AGC1 and LDD in humans 104. Lumbar disc degeneration has also been 
associated with polymorphisms in vitamin D receptor gene (VDR) 105 106 81 and matrix 
metalloproteinase-3 gene MMP-3 107. All these polymorphisms found in OPLL and LDD 
(diseases closely related and presenting simultaneously with LSS), support the theory 
that LSS could also be influenced by genetic factors 20. 
 
Noponen-Hietala et.al were the first to investigate candidate genes of LSS based on 
genes identified in related diseases. The study subjects comprised of 29 probands (LSS 
positive) and 56 controls (LSS negative) from the Finnish population. The phenotype 
was established using both CT and MRI. The following 9 candidate genes were 
selected – COL1A1, COL1A2, COL2A1, COL9A1, COL9A2, COL9A3, COL11A1, 
COL11A2 and AGC1. The study also included 2 SNPs in VDR gene and one SNP in 
MMP-3 gene promoter. The study was able to identify two variants in COL9A2 gene – 
(i) a>c in IVS26-2, and (ii) Gln326 >Trp (Trp2 allele). An Arg103>Trp (Trp3 allele) change 
in COL9A3 was also found. The previously reported a>t polymorphism in IVS6-4 of 
COL11A2 (from OPLL studies in Japanese populations) did not show any significant 
association between LSS and Finnish population. The authors justified this result by 
stating the fact that OPLL is not prevalent among Finnish population, and that the 
previously identified COL11A2 polymorphism is related to OPLL alone and not LSS in 
general. However, the frequency of the t allele was significantly higher in probands 
(93.1%) than the control group (72.3%). Further analysis showed that while the 
frequency of t/a and a/a genotypes was not significantly varying between the probands 




dominant effect. They estimated that 20% of the affected subjects in the population 
could attribute their diseased state to the high-risk t/t genotype. Analysis of the other 
previously reported polymorphisms in AGC1, VDR and MMP-3 genes showed no 
significant differences in allele frequencies between the proband and control groups 20. 
Hyon et.al (2011) based their study on the findings of the Noponen-Hietala et.al. study 
(2203). The authors studied COL9A2 gene as a candidate gene for LSS in the Korean 
population 21. Using MRI to establish phenotype, the study had 205 proband and 101 
control subjects. The study identified 42 COL9A2 polymorphisms along with the 
previously reported Trp2 allele found in Finnish population study 20. Out of the 43 SNPs 
identified, further analysis was done on the six that were present in the exons (and had 
a minor allele frequency of at least 20%), but none were statistically significant that 
could signal possible causal nature. This led the investigators to search for hidden 
susceptibility alleles in COL9A2 for LSS by studying the haplotype structure of the gene. 
The authors were able to identify the HAP2 haplotype (GCAGCG) overexpressed in 
probands (p=0.023 and odds ratio=1.86) and HAP4 haplotype (TCAGCG) 
overexpressed in controls (p=0.042 and odds ratio=0.52). The authors concluded that 
COL9A2 does indeed play a role in lumbar spinal stenosis but the mechanism behind 
this involvement remains unknown. The authors suggest a possible reason for this 
observation – mutations in COL9A2 promoter region can affect the level of collagen IX 
protein in relevant tissues by down-regulating expression 21.  
 
Treatment  
There is no cure for LSS. Management of the symptoms, either by surgery or 
conservative means, is the only effective course of action 25. The common perception is 
that LSS is a progressive disease and conservative treatments are ineffective, only 
surgery is effective and has long-term effectiveness 108 109. Non-surgical treatments of 
LSS have also shown some success for mild and moderate cases of LSS. However, 
there are no standardized protocols for conservative management of LSS to guide 
physicians. Medications are used to control the symptoms of pain and discomfort. This 




and opioids. Dosage is based on individual cases and the discretion of the physician. 
Physical therapy is an essential aspect of treatment of this disease. Exercise is believed 
to condition the body against the deleterious effects that might be the result of inactivity 
due to pain and discomfort. However there are several contradictory scientific reports 
that either support or discredit this belief. Epidural injections are another form of pain 
management. But the most commonly preferred form of treatment of LSS is neural 
decompression surgery. This procedure usually involves the removal of thickened 
connective tissue and/or osteophyte formations relieving the pressure on the nerve 
tissue inside the spinal canal. In fact most studies on LSS focus on the before and after 
aspect of neural decompression surgery. The success rate of surgery ranges from 26% 







Anatomy of the normal canine lumbosacral spine 
The anatomy of the spine in dogs is very similar to the anatomy of the spine in humans. 
The arrangement and layout of the musculoskeletal elements follow a similar pattern. 
However there is one distinct difference – the canine lumbar and sacral vertebral 
segments are not separate entities as in humans, but are often considered to be one 
single unit called the “lumbosacral” segment. The lumbosacral vertebral canal is 
considered to be one continuous element comprising of the 5th to 7th lumbar (L5 to L7) 
and the 1st to 3rd sacral (S1 to S3) in that order. Another difference from human 
anatomy is the fusion of the three sacral vertebrae to form the sacrum. The vertebral 
laminae, articular processes, pedicles and bodies of each of the L5-S3 vertebrae make 
up the canal boundary. The space in between the caudal aspect of one vertebrae and 
the cranial aspect of the adjacent vertebrae is the intervertebral foramen. The shape of 
the vertebral canal in transverse profile is usually round or oval with the transverse 
diameter tending to be greater than the dorso-ventral diameter 111. The shape of the 
lumbosacral canal becomes progressively semi-circular or crescent shaped as it 
transitions from the cranial to the caudal end of the canal 112. The cross-sectional area 
of the canal is at its greatest at mid-lumbar level and gets progressively narrower both 
cranially and caudally to that.  
 
The spinal canal and the vertebral column start developing in the embryo together at the 
same rate, but later on the vertebral column overtakes the spinal cord in the 
development rate. This results in the vertebral column extending beyond the conus 
medullaris (termination point of the spinal cord), so the nerves and nerve roots of 
vertebrae towards the end of the spinal cord have to travel longer to exit caudally to 
their corresponding vertebra. This forms a bundle of neural tissue called the “cauda 
equina” residing in the empty space inside the vertebral canal caudal to the cord. The 
dorsal and ventral roots of each spinal nerve have separate origins but unite to form a 
single spinal nerve that passes through the intervertebral foramina and immediately 




L7, S1, S2 and S3) nerve roots contribute to the lumbosacral plexus, which controls the 
hips, hind limbs, tail, urinary bladder, rectum, anus, and external genitalia. The 
ligamentum flavum or interarcuate ligament (dorsally and dorso-laterally), intervertebral 
discs and the dorsal longitudinal ligament (ventrally) form the soft tissue boundary of the 
lumbosacral vertebral canal. The caudal ligament anchors the cord caudally. The 
ligamentum flavum is a loose, elastic sheet that bridges the arches of adjacent 
vertebrae in the dorsal vertebral canal. Laterally, it is continuous with the joint capsules 
surrounding the articular processes. The intervertebral disc that sits between the 
individual vertebrae consists of a central nucleus pulposus, and an outer annulus 
fibrosus. The dorsal longitudinal ligament lies on the dorsal surfaces of the vertebral 
bodies, in the ventral portion of the vertebral canal. It is narrow at the middle of the 
vertebral body and wide over the intervertebral disc. The caudal ligament is a 
continuation of the dura mater and attaches to the periosteum of the 5th or 6th caudal 
lumbar vertebra.  
 
The spinal branches of the lumbar arteries, which arise from the abdominal aorta, 
supply arterial blood to the caudal spinal cord. The venous drainage for the spinal cord 
is primarily through the internal vertebral venous plexus. The plexus consists of paired 
interconnected vessels extending from the skull to the caudal end of the vertebral 
column. These paired vessels lie inside the ventral side of the canal nestled among the 
epidural fat. The spinal veins originate from the venous plexus following the same path 
as the nerve roots, entering and exiting through the intervertebral foramina.  
 
The caudal spinal cord and the cauda equina nerve roots are cushioned by three layers 
of meninges, that together form the thecal sac. The meningeal layers consist of the dura 
mater, arachnoid membrane, and the pia mater. The outer dura mater consists of 
longitudinal collagen bundles that cover the cord and nerve roots as they exit the canal, 
becoming continuous with the epineurium and perineurium of the spinal nerves. The 
dura is separated from the periosteum of the vertebral canal by a wide epidural space 




terminale and the caudal ligament. The middle layer or arachnoid membrane is 
separated from the inner pia mater by the subarachnoid cavity. This space is filled with 
cerebrospinal fluid. The arachnoid membrane is joined to the underlying pia by 
trabeculae. The pia mater is affixed tightly to the surface of the cord, and is usually one 
cell layer.  It is thickened laterally to form denticulate ligaments that attach the cord to 
the dura. The thecal sac is more round than oval like the vertebral canal and the 
diameters are at their greatest at the L4-L5 level, narrower cranial to L4 and wider 
caudal to L5.  
Etiology and pathogenesis  
Lumbosacral stenosis (LS) is a multifactorial neuro-orthopedic disorder similar in nature 
to human LSS 7. The classical definition of LS in dogs is – an abnormal narrowing of the 
lumbosacral canal, vertebral canal, and/or the intervertebral foramina between the L5-
S3 segments that can lead to the compression of the neural and vascular tissues inside 
the canal 7 8. Cauda equina syndrome (CES) 113 is often a direct result of said 
compression, so most of the clinical symptoms of LS often overlap with those of CES 
114. Canine LS also has multiple etiologies (similar to human LSS) –congenital 
(developmental or idiopathic), or acquired (degenerative or post-traumatic) 7 115 5 116. 
Also similar to humans, acquired or degenerative LS is the most commonly observed 
type of LS. However there is a theory that instead of any one distinct type of etiology, 
canine LS might be a combination of two etiologies – both congenital and degenerative 
117 4. This theory is supported by the fact that most dogs start showing symptoms of LS 
at a young age, well before degenerative changes should theoretically present 
themselves. Another similarity with human LSS is that canine LS can also affect the 
vertebral column across multiple vertebral levels, and affects not just the neural tissue 
but also the vascular tissue – thereby also explaining the pathology behind intermittent 
neurogenic claudication 118 62 65 119 60. 
 
Some studies in humans have documented that individuals who get clinical signs of 
LSS at a later age usually have pre-existing, subclinical bone malformations like 




in dogs positive for spinal conditions like congenital LS 13 121 9 122. The more common 
degenerative form of LS usually results from a combination of several degenerative 
changes including hypertrophied interarcuate ligament (ligamentum flavum), epidural 
fibrosis, osteophytes, disc herniation or hypertrophy, spondylolisthesis and/or 
spondylosis 115 5 116 114. 
 
Clinical presentation 
The most commonly observed neurological symptom of LS is intermittent lameness and 
weakness in motor functions of the hindlmbs, which can progress to atrophy of the 
hindlimb muscles and paresthesia (physically inexplicable sensation of 
tingling/tickling/pricking/burning of the skin). Paresthesia can in turn lead to self-
mutilation of the hindlimbs, tail, perineum, anal area and genitalia that is unrelated to 
any other dermatological condition. Other symptoms include vocalizing during exercise; 
difficulty in standing up, sitting or lying down; low carriage of the tail; kyphosis 
(abnormally excessive convex curvature of the spine); stiff or unnatural gait; dragging of 
paws; hypotonia of the tail; and last but not the least urinary and fecal incontinence 123 
124 125. Most of these symptoms usually overlap with other neuro-orthopedic and/or 
musculoskeletal disorders like cauda equina syndrome 116, osteoarthritis 126, 127, and 
intervertebral disc degeneration 128. 
 
Even though Tarvin (1980) was the first to report LS in dogs, his study comprised of 
mostly small breeds 7; since then a trend has been identified – LS usually affects larger-
sized dog breeds 16 129 130. German shepherds are the breed that is most represented 
123 124 125; but other high risk breeds include Labrador retrievers, Rottweilers, Bernese 
Mountain dogs, Boxers, Dalmatians, Irish setters, and Doberman pinschers 130. 
Lumbosacral stenosis also appears to affect males more than females (again similar to 
human LSS) 123 124 130 115 5 6 125. Possible reasons for this gender-specific trend are: 
male dogs are usually heavier in size, faster in their growth rate and are selected more 
often for strenuous physical activity 123. The average age of onset for LSS is around 7 





Clinical diagnosis and diagnostic imaging 
The primary symptom presented by majority of dogs with degenerative LS is reduced 
physical activity and pain sensitivity in the lumbosacral region (on external manual 
palpation) 114. However, positive diagnosis of degenerative LS can be complicated by 
the subtle nature of the clinical signs: (i) symptoms might not appear until the dog 
undergoes hard physical exertion; (ii) symptoms can mimic those of other spinal 
diseases like intervertebral disc degeneration (IVDD) diseases 131, degenerative 
sacroiliac joint disease (DSJD) 132, foraminal stenosis 133, Schmorl’s nodes 134; and (iii) 
dogs being unable to vocalize pain, masking signs of pain especially the high-drive 
breeds, and/or dogs asymptomatic at the time of examination. Another concern of 
diagnosing LS in dogs based on clinical symptoms is the unreliable nature of how a dog 
responds to pain or discomfort.  
 
Diagnosis of LS is most commonly performed using CT and/or MRI because 
conventional radiographs are usually unable to capture the spinal canal in the trans-
axial plane – where most of the signals for lumbosacral stenosis are present. Computed 
tomography is a well-established non-invasive diagnostic imaging technique used for 
evaluating the lumbosacral spine in dogs 135 111, 115 136 112, and has been used to study 
lumbar spinal diseases like spina bifida 137, IVDD 138 and vacuum phenomenon of the 
spine 73. The advantages of using CT over MRI in veterinary practices include: (i) 
greater availability; (ii) lower cost; and (iii) shorter duration allowing for reversible 
sedation instead of general anesthesia. Tarvin (1980) identified L6-L7 and L7-S1 
transitional locations as the most at-risk vertebral segments for LS.  
 
Qualitative and quantitative computed tomography characteristics 
Fingeroth (1989) was the first to use CT for the clinical diagnosis of a spinal disease in 
an English bulldog 137. Since then CT has become a commonly used imaging technique 




lumbosacral spine of 9 large breed dogs clinically diagnosed with LS, and then 
confirmed the said imaging anatomy with surgical evaluation 139. The commonly 
observed CT abnormalities in these dogs (with surgically confirmed LS) were: loss of 
epidural fat, increased soft tissue opacity, bulging in the intervertebral disc margin, 
spondylosis, displacement of the thecal sac, narrowed intervertebral foramina, narrowed 
vertebral canal, thickened articular processes, subluxation of the articular processes, 
bone spurs in the articular processes, and telescoped sacral lamina. The authors 
acknowledged the possibility that all these traits might not be true clinical signs of LS 
since some of the traits were also detected in dogs with no signs of LS. However, the 
study was able to identify 2 possible qualitative traits of LS – loss of epidural fat and 
loss of soft tissue transparency that was observed in all of the 9 dogs positive for LS. 
Other observed traits with a high frequency included disc bulging, spondylosis, and 
thecal sac displacement (findings also supported by studies of human LSS). Epidural 
fibrosis was another trait observed only in surgery but not directly in the CT images. An 
ill-defined region of soft tissue opacity and loss of nerve root/thecal sac visualization 
were the only observable characteristics of fibrosis in the epidural region in CT images – 
cause and significance of which is not well understood in dogs 116 115. Human studies 
have suggested that epidural fibrosis might be a post-surgical complication rather than a 
spontaneous phenomenon 135 82, 83. Some of the qualitative traits observed were not at 
the exact site of neural compression but in adjoining vertebral segments, thus also 
hinting at a possible multi-level etiology of canine LS 7. The clinical symptom of 
neurological claudication has been attributed to this multi-level phenomenon in human 
LSS 62 60.  
 
Feeney et.al (1996) published a morphometric study to quantify the normal canine 
lumbosacral spine 140. The subjects in this study were three Beagles and three mixed-
breeds. The canal and foramen diameters as well the thecal sac diameters were 
measured manually in transverse CT images. The average intervertebral foramen 
diameter range was 0.20cm – 0.30cm. Epidural fat was found to be present on all 




epidural fat and body weight of the dog. To compensate for the difference in body size 
of the different dogs, all the measurements were standardized based on the 
measurement of the least variable L6 vertebral mid-body. Despite the standardization, 
significant variation was observed among the six dogs. The vertebral canal was oval but 
the thecal sac was more circular in profile, and the space within the canal that was not 
occupied by the thecal sac was filled up by epidural fat. The authors proposed cautious 
interpretation of the loss of epidural fat in the vertebral canal as a symptom of stenosis 
139, since it could just be normal anatomical adjustment instead of a clinical symptom. 
However this study did not state any absolute values to define a normal lumbosacral 
spine and only recorded for any significant differences among the dimensions measured 
in the six dogs of the study. The morphometric study of the lumbosacral spine by Jones 
et.al had a larger sample size of 42 large breed dogs (21 cases and 21 controls) and 
included dogs from multiple breeds 112.   
Genetic characteristics 
The modern day dogs we observe today have become an essential part of the human 
way of life 141.  Dogs (Canis lupus familiaris) are in fact the domesticated sub-species of 
the grey wolf (Canis lupus) 142. The oldest dog domestication records found date back to 
approximately 15,000 years, but some studies argue that the first canine domestication 
event could have happened up to 100,000 years ago in Eastern Asia 143 142 144. Humans 
and dogs have evolved in parallel with each other over time 145, sharing living space and 
food sources based on a mutually beneficial relationship – thus making the comparative 
analysis of the human genome possible due to the shared environment which in turn led 
to shared evolution 146. This unique shared history among humans and dogs makes the 
canine species a perfect model to explore the genetic basis of diseases, variation in 
morphology and behavioral traits – with respect to not only how it affects the canine 
species but also how similar disease processes might affect humans.  
 
After the initial phase of domestication, dogs underwent extensive artificial selection due 
to their intentional breeding by humans focused on fixing specific traits – resulting in the 




of canine breeds, population structure within each breed is relatively homogenous and 
is comparable to the population structure observed in geographically isolated human 
populations148,149 150 151 147 152 153.  And similar to human populations, certain dog breeds 
have a higher prevalence for certain diseases than other breeds 154. This further 
enhances the desirability of the canine model for human biological research – diseases 
with unknown etiology in humans are often first studied in smaller geographically 
isolated population in which the disease has a higher than normal incidence, before the 
findings can be translated to a larger population. Another factor that makes dogs such 
good models is that most canine diseases also have a version that affects humans often 
with similar clinical manifestations 155. Other key factors that make dogs good models 
for human disease studies include: 1) dogs usually enjoy high quality of medical care 
alongside humans for similar medical conditions; 2) both being mammals, dogs and 
humans are comparable to each other both anatomically and physiologically; 3) dogs 
generally cohabit with humans thus negating the effects of differing environmental 
exposures; 4) many human diseases occur naturally in dogs thus there is no need for 
chemical or mechanistic techniques to artificially induce the disease state; and 5) dogs 
have shorter life span, allowing for longitudinal studies to observe the progression of 
diseases over time 156. This unique relationship between dogs and humans, and the 
success of the canine model for human disorders, would allow bidirectional beneficial 
flow of information – findings in canine studies would not just benefit humans, but 
finding in human studies could also be applicable in dogs 151. Genetic analysis of a 
diverse array of traits in dogs has provided further proof supporting this theory. The 
canine genome has been completely sequenced by the Broad Institute in 2003 149. More 
than 650 million base pairs (more than 25%) of the dog sequence align uniquely to the 
human genome including orthologs for 18,473 of the 24,567 annotated human genes 
157. For certain traits the dog genome is more similar to humans that the common rodent 
models 158.  
 
Some genetic factors (especially those dealing with collagen genes) have been implied 




previous studies 20 21. No such genetic studies have been conducted in dogs except a 
pedigree association study of LS in German shepherds 11. However to the best of our 
knowledge, no genetic association study has been reported that focuses on LS in 
Labrador retrievers. The canine model has found success in study of several human 
musculoskeletal diseases that include intervertebral disc disease (IVDD) 159; Duchenne 
Muscular Dystrophy (DMD) 160; and osteoarthritis (OA) 161. Quantitative diagnostic 
imaging has been used to study other human diseases in canine models in diseases 
like ischemic renal disease 162.  Experimental bone regeneration has also found some 
success in the canine model in recent years 163 164. Delamarter et.al introduced an 
experimental canine model for LSS in 1990 165. However, larger sized breeds like the 
German shepherds and Labrador retrievers would make them better models for LSS, 
since the disease process of LS in these breeds is more organic and natural. 
 
Treatment  
Tarvin (1980) was the first to report treatment plan for LS in 15 dogs 7. The dogs were 
treated conservatively with anti-inflammatory drugs and Elizabethan collars (or E-
collars) to prevent the dogs from self-mutilating themselves. Similar to LSS in humans, 
the most popular treatment approach is surgical – decompression by deep dorsal 
laminectomy in combination with lateral foraminotomy of the affected vertebrae 7 166. 
Laminectomy and foraminotomy both involve the removal of hypertrophied tissue to an 
extent that the neural tissue inside the vertebral column is no longer compressed 
thereby also relieving the pressure on the vascular tissue. The treatment strategies 
have not changed much over the last 30 or so years 167. Non-surgical therapy still 
involves oral analgesics or anti-inflammatory drugs to provide symptomatic pain relief 
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CHAPTER III. PHENOTYPIC CHARACTERIZATION OF LUMBOSACRAL STENOSIS 
IN LABRADOR RETRIEVERS  
III.1: Introduction  
 
The definition of lumbar spinal stenosis (LSS) is the structural narrowing of the lumbar 
spinal canal, nerve root canal and/or intervertebral foramina 168 17. Clinical symptoms 
may arise when this narrowing results in compression or entrapment of the underlying 
nerve tissue, meninges and/or blood vessels inside the vertebral canal 168 66. Lumbar 
spinal stenosis can be confined to a single vertebra or spread across multiple vertebral 
levels 169 170 17 171 172 173 174. Lateral canal or foraminal stenosis is a specific type of LSS 
that involves the lateral portions of the vertebral canal or intervertebral foramina. Based 
on the time of onset, LSS can also be classified as either primary stenosis (narrowing 
due to congenital or developmental malformation) or acquired stenosis (narrowing due 
to encroaching proliferative tissues and/or vertebral malalignment).  Acquired or 
degenerative causes of stenosis include facet joint arthrosis or hypertrophy, thickening 
and bulging of the intervertebral disc, hypertrophy of the ligamentum flavum and/or 
spondylolisthesis. Some studies have also implicated genetics as a factor in the 
pathogenesis of human LSS 20 21. 
 
The canine version of LSS is known as lumbosacral stenosis (LS) 7. The larger sized 
working/sporting breeds of dogs are predisposed to LS 8 123 16 175 129 115 5 6 24 112 139. 
Labrador retrievers are the most popular household pet dog breed in the United States 
15 and also one of the most common breeds used worldwide as working dogs  123 16 3 
176. This breed is also considered to be at high-risk for LS 130.  
 
X-ray computed tomography (CT) is an accepted non-invasive method for deep 
phenotyping of LSS in humans 177 178 89 179 77 75 44 180 83  181 182 91 71  183 184 185; as well as 
LS in dogs 186 187 188 189 16 190 79. The current standard CT methods for phenotypic 




surgically confirmed presence of LS 139 191 129 16 190. These criteria include loss of 
epidural fat, increased soft tissue opacity, bulging of intervertebral disc, spondylosis, 
thecal sac displacement, narrowed intervertebral foramen, narrowed vertebral canal, 
narrowed articular processes, articular process subluxation and articular process 
osteophytosis 139. For research purposes, quantitative criteria for phenotyping LS would 
be desirable because they would allow for use of more powerful parametric statistical 
tests.  
 
Quantitative CT measures of human LSS have been extensively described, however 
traits measured and values used for defining stenosis have varied between reports 178 76 
86 75  192 91 193 30 194. Cross-sectional vertebral canal area, antero-posterior diameter and 
inter-pedicular diameter measurements of the spinal canal are the most commonly 
described quantitative traits in humans 75 179 86 92 192 83 78 195 90 196. Other measurements 
reported include the following: mid-sagittal vertebral canal diameter, lateral recess 
sagittal diameter, transverse thecal sac area, inter-facet ligamentous diameter and 
thecal sac diameter.  Cross-sectional area measurements offer an advantage over 
diameter measurements because they are more likely to detect asymmetrical canal 
narrowing or lateral canal narrowing 86 75 91 92 90. However, despite the established 
definition of stenosis being “narrowing”, there are very few evidence-based reports 
where the “stenotic” vertebral canal area range has been defined, or compared with 
“normal” area measurements 86, or the threshold value agreed upon. The contradictory 
threshold values for a stenotic canal range anywhere from 0.85 cm2 83 to 1.45 cm2 75. 
Another study assigned 1.4 cm2 as the stenosis threshold 90.  No such studies exist in 
dogs that focus on quantitatively differentiating between “stenotic” and “non-stenotic” 
canals. There is one previous canine study that did a morphometric comparison 
between quantitative CT characteristics of the lumbosacral vertebral canal in dogs with 
versus without symptoms of cauda equina dysfunction 112, but not LS.  Vertebral canal 
diameter and area values were found to correlate with adjacent vertebral body 
dimensions in asymptomatic dogs, therefore ratios of vertebral canal and vertebral body 




comparisons.  Differences between groups were found for ratios of vertebral canal 
transverse area to vertebral body transverse area at caudal L5 (0.42 LS, 0.46 control) 
and caudal L6 (0.36 LS versus 0.44 control). However, this study included dogs from 
multiple breeds and the study was able to quantify only bony canal stenosis (soft tissue 
stenosis was not quantified).  Also, at the time of the previous study, availability of 
advanced CT image analysis softwares that allow for both manual and automated 
measurements of selected structures of interest were limited.  To the authors’ 
knowledge no published reports have compared CT quantitative measures to qualitative 
assessments of LS. 
 
The aims of this current study were to develop a CT quantitative method for 
characterizing the morphologic phenotype of LS in Labrador retrievers and to compare 
findings from this method with findings from current standard qualitative CT methods. 
The hypotheses of this study were: 1) ratios of CT vertebral canal transverse area to 
vertebral body transverse area, and novel ratios of vertebral canal transverse epidural 
fat content area to vertebral body transverse area can be used to quantify LS in 
Labrador retrievers; and 2) the assessment of LS made using these quantitative 
measurements will yield results comparable to the current standard qualitative 





III.2: Materials and Methods 
Study samples  
This cross-sectional retrospective study was based on CT scans and medical records of 
Labrador retrievers obtained from three sources: the Holland Military Working Dog 
Hospital at the Lackland Air Force Base, Virginia-Maryland Regional College of 
Veterinary Medicine Veterinary Teaching Hospital and the University of Pennsylvania 
Ryan Veterinary Hospital/Working Dog Center. A board certified veterinary radiologist 
(JJ) reviewed the scans to ensure they met inclusion criteria.  The scans had to contain 
the lumbosacral region and evidence of no previous lumbosacral surgery, neoplasia, 
fractures or infection in order to be included in the study.   
 
Computed Tomography  
All included scans were analyzed using CT image analysis freeware (OsiriX DICOM 
Viewer, Version 4.2) and image analysis workstations (Mac Pro and MacBook Pro Apple 
Inc. Cupertino, CA). Under the supervision of a board-certified veterinary radiologist (JJ), 
a single observer (MM) independently measured and recorded quantitative values while 
unaware of qualitative CT findings and medical history. After a delay period, the 
veterinary radiologist then recorded a qualitative diagnosis of presence or absence of LS 
at each of the vertebral locations using standard criteria. At the time of interpretation, the 
radiologist was unaware of quantitative or medical record findings.  After quantitative CT 
measurements were completed, the same observer (MM) then made note of the age, 
sex, body weight, low back pain (LBP) status and working status; as entered into the 
medical records at the time of the original CT scan. 
 
Slice thickness for each study was standardized at 5 mm using the software’s “thick slab 
mean mode” tool in order to maximize contrast resolution for soft tissues and minimize 
sources of partial volume averaging variability between studies 197 135. The following 
quantitative CT phenotypic variables were measured in triplicate at each of six vertebral 




(caudal L5, cranial L6, caudal L6, cranial L7, caudal L7 and cranial S1) 7 139 (Figure III.1): 
vertebral canal area, vertebral body area and vertebral canal fat area. Vertebral canal 
area at each vertebral location was measured using a bone window setting (WL 300, 
WW 1500) tracing the canal boundary with a pencil tool ensuring the surrounding bone 
did not get included inside the tracing (Figure III.2A). Using the same pencil tool and 
window setting, the vertebral body area was traced ensuring that no surrounding soft 
tissue was included. The vertebral canal fat area at each vertebral location was 
measured in a soft tissue or “abdomen” window (WL 40, WW 350), using segmentation 
tools to set the lower and upper threshold at -200 and 0 Hounsfield units (HU) 
respectively (Figure III.2B).  A region of interest (ROI) was generated automatically by 
clicking the cursor over all locations within the canal where fatty tissue appeared to be 
present (visibly darker color grey than other soft tissue). All area values were measured 
in cm2. The means of all triplicate measurements were calculated. Vertebral 
canal/vertebral body area ratio (CAR) 112 and canal fat area/vertebral body area ratio 
(FAR) (novel methodology) were then calculated from the means at each location for 
each dog.  
 
Canal stenosis was qualitatively assessed and recorded as present or absent for each 
dog at each of the six vertebral locations. The assessment was done twice in two 
separate reading sessions by the same veterinary radiologist (JJ). To minimize read 
bias, scans were interpreted in random order and the second reading session was done 
three days later, at a different time of day and in a re-randomized order. In cases where 
there was a discrepancy between the first and second readings, the radiologist made a 
third assessment that was deemed to be the final decision. For purposes of this study, 
qualitative stenosis at a vertebral location was considered to be present if the radiologist 
detected at least two of the following CT lesions: thickened pedicle(s), thickened 
lamina(e), loss of epidural fat on opposing sides of neural tissue, proliferative bone or 
soft tissue in the canal and/or a subjectively narrowed canal 7 175 198. Stenosis was 






A single statistician (IH) selected and performed statistical tests using commercial 
software (JMP®, Version Pro 11, SAS Institute Inc., Cary, NC, Copyright© 2013). Dogs 
were grouped under the following clinical data categories for analyses: sex – M (male) 
or F (female); LBP status – absent or present; and working status – working or non-
working.  Age and weight were treated as continuous variables. Significance criterion 
alpha for all tests was set at 0.05 (5%). Initially, continuous variables such as canal area 
ratios (CAR) and fat area ratios (FAR) for each of the 6 vertebral locations in all dogs 
were screened for normal distribution using the Shapiro-Wilk W test 199. Lack of 
normality was detected in CAR for L5Cd, L6Cd and L7Cd. Negative inverse (-1/x) 
transformation was applied to L5Cd, while L6Cd and L7Cd were natural log ln(x) 
transformed. Variance equality in CAR and FAR between LS positive and LS negative 
dogs (assigned based on CT image analysis) were inspected using Levene’s test 200. T-
tests were used to test the null hypotheses: both quantitative measurements (CAR and 
FAR, independently) are not different in LS positive from LS negative dogs (based on 
the qualitative CT assessment). Secondary analysis included logistic regression with 
dichotomous response 201 – LS positive or LS negative based on qualitative CT 
assessment, where CAR and FAR were applied as explanatory continuous variables to 
predict the presence or absence of LS, done individually for the 6 different vertebral 
locations in the lumbosacral spine. Logistic regression analysis allowed the examination 
of the variables (CAR or FAR), as to which quantitative measurement would be the 
better predictor for the probability of being LS positive based on the CAR (or FAR) 
measurements at a specific vertebral location. The predicted probability curves of LS 
based on logistic regression were generated for each location.  Untransformed data 
were used for plot constructions. Significance was defined as p < 0.05 after Benjamini-






This analytical cross-sectional retrospective study comprised of CT scans collected 
between the period of 1997 and 2013, and included scans from a total of 25 Labrador 
retrievers that met the inclusion criteria. The scan of one of the 25 dogs in the study, 
included only four of the six vertebral locations (L6 caudal, L7 cranial and caudal, and 
S1 cranial). For the two missing locations (5th caudal and 6th cranial lumbar vertebra), 
analyses were performed on 24 dogs.  The study involved 17 males and 8 females.  
The ages of the subjects ranged from 11 months to 14 years (mean 6.46 ±0.84 years).  
Dog weights ranged from 23.6 kg to 44 kg (mean 32.3 ±1.13 kg). 9 dogs showed signs 
of lower back pain at the time of CT examination. Six of these 9 dogs were older than 5 
years of age. The remaining 16 dogs had no signs of lumbosacral pain. Eight dogs were 
classified as working dogs and the other 17 as non-working dogs. No significant 
correlation between age and LBP was found. The study sample population is described 
in Table III.1.  
 
Computed Tomography scans 
Twelve dogs were scanned with single slice CT scanners (IQXtra or PQ5000, Picker 
International, Cleveland, Ohio) and 13 dogs were scanned with multi-slice CT scanners 
(Aquilion, Toshiba, Tustin, CA; LightSpeed VCT or BrightSpeed, GE Medical Systems, 
Pewaukee, WI).  All single slice scans were acquired in axial mode and all multi-slice 
scans were acquired in helical mode.  The scan matrix for all dogs was 512 x 512.  
Volume scans were acquired at 0.625 mm slice thickness for 7 dogs, 1 mm slice 
thickness for 2 dogs, and 2 mm slice thickness for 1 dog.  Contiguous scans were 
acquired at 5 mm slice thickness for 2 dogs and 0.5 mm slice thickness for 1 dog.  
Scans with a 1 mm overlap were acquired at 2 mm slice thickness for 2 dogs, 5 mm 
slice thickness for 9 dogs, and 4 mm slice thickness for 1 dog.  A standard scan filter 




settings were 13-400 mA and 120-140 kVp. All the CT scans were acquired from dogs 
positioned in dorsal recumbency.   
 
Statistical analyses 
Based on the performed t-tests, the mean CAR values at the cranial end of the L7 
vertebra in LS positive dogs was significantly smaller than the mean CAR of LS 
negative dogs (p-value=0.0409). There was no statistically significant difference in 
CARs between the LS positive and LS negative dogs at any of the other 5 locations 
(Table III.2) (Figure 3).  The t-tests for mean fat area ratios (FARs) indicated that FARs 
for LS positive dogs were significantly smaller than FARs for LS negative dogs across 
all 6 vertebral locations (Table III.2) (Figure 4). Logistic regression analysis between 
quantitative CAR measurements and qualitative CT diagnoses of LS (standard test) 
showed no statistical significance at any of the six vertebral locations (Table III.3) (data 
not shown). Logistic regression between quantitative FAR measurements and the same 
qualitative CT diagnoses showed statistically significant associations at each of the six 
vertebral locations (Table III.3) (Figure 5). Predicted probabilities for LS positive dogs (y 
axis) against FAR measurements (x axis) for all six locations were plotted based on our 
model and are represented in Figure 6. All of the predicted probability curves had high 
R2 values (L5Cd=0.999; L6Cr=0.997; L6Cd=0.998; L7Cr=0.998; L7Cd=0.991; and 
S1Cr=0.997) and displayed a pattern of increase in the probability of being LS positive 







The purpose of this study was solely to develop a quantitative CT method for structural 
phenotyping of LS (that could be comparable with traditional qualitative detection 
methods) in Labrador retrievers – facilitating research related statistical analysis, and 
not diagnosis of LS for clinical applications. Clinical detection of lower back pain can be 
unreliable as an outward indicator of LS in dogs, especially in stoic and high-drive dogs 
such as Labrador retrievers. Hence the need for deep phenotyping using advanced 
imaging modalities like CT and MRI. While qualitative assessment of scanned images is 
the standard for clinical applications with regards to LS in dogs, statistical analyses are 
strengthened with quantifiable variables. 
 
Our first hypothesis was that quantitative CT measurements could quantify LS in 
Labrador retrievers. We started with two measurements: canal area ratio (CAR) and fat 
area ratio (FAR), however the most significant results were achieved by the novel 
measurement (FAR) in quantification of LS. Stenosis has been defined as narrowing of 
the spinal canal, CAR was assumed (and has been used in previous studies 112) to be a 
vital numerical measurement that could signal stenosis. Transverse canal area ratios 
were used instead of absolute values to compensate for difference in body sizes of the 
dogs (bigger dogs have bigger vertebral canals and vertebral bodies; and vice versa). 
Loss of epidural fat at the location of stenosis has also been reported as one of the 
most frequently observed CT lesions for surgically confirmed stenosis in dogs 139. To 
compensate for the difference in body sizes of the dogs and be comparable to CAR (the 
other measurement), we chose to use FAR (fat-content transverse area with vertebral 
body transverse area) instead of the absolute values.  
 
Our second hypothesis was that the assessment of LS made by CT quantitative 
measurements would yield results comparable to current standard qualitative CT 
assessment of LS in Labrador retrievers. Findings supported one part of our hypothesis 




show statistically significant agreement with the qualitative assessment made by the 
board certified veterinary radiologist. However, the novel quantitative measurement 
(FAR) had significant agreement with the standard qualitative assessment of LS. Canal 
area ratio was found to differ at some vertebral locations in dogs with versus without 
signs of cauda equine nerve dysfunction 112, however to our knowledge, no previous 
papers have compared quantitative and qualitative CT characteristics of stenosis in 
dogs. There are no reported threshold values for any quantitative traits that measure LS 
in dogs. The predicted probability curves (based on logistic regression between LS and 
FAR measurements) supported our study hypothesis in that a decrease in the FAR at a 
vertebral canal location (L5Cd, L6Cr, L6Cd, L7Cr, L7Cd and S1Cr) increased the 
probability of the vertebral location being classified as LS positive by an expert reader.  
These probability plots provide preliminary evidence that FAR threshold values may be 
used for determining LS positive or negative status at individual vertebral locations in 
Labrador retrievers. Further investigations in larger samples of Labrador retrievers are 
needed to establish the FAR threshold values for LS status in this breed, at each of the 
vertebral locations of the lumbosacral spine. The process could also be repeated in 
other breeds of dogs to develop breed-specific FAR threshold values. 
 
This study had the following limitations: small sample size, manual tracing 
measurements of vertebral canal area and vertebral body area, use of only one 
radiologist for qualitative assessment and only one observer for the quantitative 
measurements, and different CT technique settings used at the time the scans were 
acquired. Our choice to focus on Labrador retrievers limited our sample size, but helped 
minimize outside variability due to breed differences that could have interfered with our 
analyses. We attempted to maximize the sample size by seeking cases from 3 different 
hospitals.  We also included a dog whose scan covered only four of the six locations, to 
maximize the sample size for the available four locations.  
 
The study had roughly equal number of LS positive and LS negative dogs (11 LS 




group (average age = 8.07	   ± 0.99). Males were affected more than females in the LS 
positive group (in agreement with previous reports). Low back pain status did not have 
good agreement with LS status (also consistent with previous reports). Only 6 of the 14 
LS positive dogs were also LBP positive, and 5 out of these 6 dogs were older than 5 
years of age. Findings subjectively supported the theory that younger LS positive dogs 
may not initially present with clinical signs of LBP and that the likelihood of lower back 
pain detection may increase with age, however no statistically significant association 
could be demonstrated due to small sample size. Small sample size also inhibited the 
testing of associations between qualitative LS assessments and any of the other 
demographic data – none were significant.  
 
Making triplicate measures and using an average of these measures for analyses 
minimized observer effects in manual measurements.  Using only one observer for the 
measures and one radiologist, another external source of variability was minimized. 
However this prevented us from performing inter-observer repeatability tests for the 
methodology. Being a retrospective study, the study had no control over the technical 
CT settings used at the time of the scan – another possible source of external 
variability. But this could also be an advantage since the results can be applicable to a 
wide range of CT settings. Attempts were made to reduce variability due to different 
technical settings by standardizing the settings in the image analysis freeware (Osirix) 
while making measurements. So, findings from the current study indicate that CT FAR 
measurements yield comparable results to qualitative CT assessment of LS by an 
expert reader for Labrador retrievers. Further studies are needed to verify the efficacy of 
FAR as a research tool for quantitative phenotyping of LS in Labrador retrievers as well 











Figure III.1. Positioning of a dog for acquiring CT scan of the lumbosacral spine.   
Photograph of a Labrador retriever positioned for CT scanning of the lumbosacral spine.  
The dog is under general anesthesia and positioned in dorsal recumbency on the CT 
table with the hind limbs flexed in order to flatten the lumbosacral angle. 











Figure III.2. Lateral CT image depicting the six measured locations of the canine 
lumbosacral spine  
Lateral localizer CT image of the lumbosacral region illustrating the locations where 
canal and fat area measurements were acquired.  L5 Cd = caudal portion of the 5th 
lumbar vertebra, L6 Cr = cranial portion of the 6th lumbar vertebra, L6 Cd = caudal 
portion of the 6th lumbar vertebra, L7 Cr = cranial portion of the 7th lumbar vertebra, L7 










Figure III.3. Representative screenshots illustrating the methodology for the quantitative 
measurements  
 (A) Transverse bone window CT image of the lumbosacral spine at L6 caudal location 
illustrating the regions of interest (ROI) that were hand-drawn for vertebral canal area 
and vertebral body area measurements  (B) Transverse soft tissue window CT image of 
the lumbosacral spine at the same location in the same dog illustrating the automated 










Figure III.4. Mean canal area ratio comparisons between LS-positive and LS-negative 
dogs. Significant difference (p ≤ 0.05) is denoted by (*). N = 25 except at 5th caudal and 
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Figure III.5. Mean fat area ratio comparisons between LS-positive and LS-negative 
dogs. Significant difference (p ≤ 0.05) is denoted by (*). N = 25 except at 5th caudal and 
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Figure III.6. Logistic regression between quantitative measurements and qualitative 
assessment of lumbosacral stenosis  
Logistic regression between the quantitative fat area ratio measurements and the 
qualitative CT diagnoses of lumbosacral stenosis for each of the six vertebral locations 
(A) L5Cd: caudal end of 5th lumbar vertebra; (B) L6Cr: cranial end of 6th lumbar 
vertebra; (C) L6Cd: caudal end of 6th lumbar vertebra; (D) L7Cr: cranial end of 7th 
lumbar vertebra; (E) L7Cd: caudal end of the 7th lumbar vertebra; (F) S1Cr: cranial end 

















Figure III.7. Predicted probabilities for being LS-positive at each of the six vertebral 
locations 
Probability of being LS-positive has been predicted based on the logistic regression 
analysis between the novel quantitative measurement of stenosis (fat area ratio or FAR) 
and the standard qualitative CT diagnosis of being LS-positive for each vertebral 
location (A) L5Cd: caudal end of 5th lumbar vertebra; (B) L6Cr: cranial end of 6th lumbar 
vertebra; (C) L6Cd: caudal end of 6th lumbar vertebra; (D) L7Cr: cranial end of 7th 
lumbar vertebra; (E) L7Cd: caudal end of the 7th lumbar vertebra; (F) S1Cr: cranial end 











CT – computed tomography LS – lumbosacral stenosis 
M – male F – female 
W – working NW – non-working 
 
  
Group CT LS negative CT LS positive 
Number 11 14 
Average Age 4.45 (± 1.08) 8.07 (± 0.99) 
Age Range 1 - 11 1 - 14 
Sex 8 M, 3 F 9 M, 5 F 
Average Weight 31.35 (± 1.22) 33.07 (±1.69) 
Weight Range 25.7 - 40.4 23.6 - 44.0 
Working status 6 W, 5 NW 2 W, 12 NW 




Table III.2.  T-test p-values for canal area ratio and fat area ratio comparisons 
between LS-positive and LS-negative dogs 
 
 
N = 25 dogs except where denoted by Ψ (n= 24 dogs) 






Canal area ratio (CAR) Fat area ratio (FAR) 
5th Lumbar caudal (L5_Cd) 0.2201Ψ 0.0391* Ψ 
6th Lumbar cranial (L6_Cr) 0.6205 Ψ <0.0001* Ψ 
6th Lumbar caudal (L6_Cd) 0.0723 0.0054* 
7th Lumbar cranial (L7_Cr) 0.0409 0.0010* 
7th Lumbar caudal (L7_Cd) 0.4287 0.0049* 




Table III.3. Logistic regression p-values – quantitative measurements (CAR and 




Logistic regression p-values 
Canal area ratio (CAR) Fat area ratio (FAR) 
5th Lumbar caudal (L5_Cd) 0.4564 Ψ 0.0390* Ψ 
6th Lumbar cranial (L6_Cr) 0.7251 Ψ 0.0003* Ψ 
6th Lumbar caudal (L6_Cd) 0.3467 0.0449* 
7th Lumbar cranial (L7_Cr) 0.0685 0.0011* 
7th Lumbar caudal (L7_Cd) 0.9307 0.0008* 
1st Sacrum cranial (S1_CR) 0.1799 0.0011* 
  
N = 25 dogs except where denoted by Ψ (n= 24 dogs) 





CHAPTER IV. GENETIC CHARACTERIZATION OF LUMBOSACRAL STENOSIS IN 
LABRADOR RETRIEVERS  
IV.1: Introduction 
 
Working dogs are high-performance athletes and vital members of teams that support 
public service, national security and military missions in the U.S. and around the world 
1. Working dogs perform a variety of tasks such as sentry-and-patrol duty; search and 
rescue; mobility support for disabled persons; and detection of explosives, arson 
accelerants, illegal drugs. Labrador retrievers are one of the most popular choices for 
use as detection dogs 3,14. The demands for detection dogs have been increasing over 
recent years 3. In particular, military forces worldwide recognize military working dogs 
(MWDs) as “force multipliers”. An American Forces Press Service release (October, 
2015) estimated the US military to have around 2,300 MWDs 
(http://usmilitary.about.com/od/jointservices/a/militarydogs.htm). The dogs represent all 
branches of the military, and together with their handlers they are deployed worldwide to 
serve American interests. All branches of the U.S. military consider MWDs to be vital for 
accomplishment of their missions and invest major financial and personnel resources 
each year to procure, train and maintain these working dogs. According to a 2011 US 
Government Pentagon memo, typical purchasing and training costs for a high quality 
MWD can range anywhere in between $20,000 to $40,000 US dollars (depending on 
the nature of MWD’s assignments, and whether the dog is trained for multiple types of 
tasks) (http://www.nytimes.com/2011/05/12/world/middleeast/12dog.html?_r&_r=0). The 
demand for high quality dogs working dogs is increasing; along with the cost of 
breeding, raising and subsequent training of the dogs. This has resulted in a decrease 
in the availability of new dogs. Therefore, ideally the military needs to have dogs that 
can maintain functionality for as long as possible. Once they are trained, the service 
lifetime of a typical MWD is expected to average about 10 – 12 years of age 




trained MWD would mean not just a financial loss for the US Military, but also a 
functional loss for the productivity of the team that depends on the particular dog.   
 
Spinal diseases are one of the leading causes for early retirement in MWDs 
2.  Lumbosacral stenosis (LS) is the most common pathological condition that affects 
the canine lumbosacral spine, especially the large breed dogs like German shepherds 
and Labrador retrievers 123 190 129 115 5 6 24 112 139 4. Labrador retriever MWDs are also 
affected by LS 16. Lumbosacral stenosis in dogs is defined as an abnormal narrowing of 
the lumbosacral canal, vertebral canal, and/or the intervertebral foramina 7. This 
morphologic problem is a risk factor for disability due to compression of the underlying 
neural and/or vascular tissues. This compression can in turn be a risk factor for clinical 
conditions such as cauda equina syndrome (CES) 8. Low back pain (LBP) on palpation 
of the lumbosacral spine is the primary clinical sign of LS in the majority of dogs 114. 
However, disadvantages of diagnosing LS based on LBP status alone include the 
following: (i) symptoms can be intermittent with appearance only after hard physical 
exertion; (ii) symptoms can mimic those of other spinal diseases like intervertebral disc 
degeneration (IVDD) diseases 131, degenerative sacroiliac joint disease (DSJD) 132, 
foraminal stenosis 133, and Schmorl’s nodes 134; (iii) stoic dogs may not consistently 
vocalize pain; and (iv) Labrador retrievers are specifically bred to be stoic and have 
high-drive – qualities desirable for the MWD job description but can also cause a delay 
in detection of sub-clinical conditions like LS. A dog can be structurally LS positive, but 
clinical signs can be absent until the condition worsens to such an extent that 
therapeutic and surgical options are no longer viable, and the only course of action for 
the military is retirement (and in severe cases euthanasia). Therefore improved 
methods for early detection of LS are critical for minimizing the risk of early retirement in 
these valuable canine athletes. 
 
Computed tomography (CT) is a well-established non-invasive diagnostic imaging 
technique used for clinically diagnosing LS in dogs 136 188. The commonly observed CT 




increased soft tissue opacity, bulging in the intervertebral disc margin, spondylosis, 
displacement of the thecal sac, narrowed intervertebral foramina, narrowed vertebral 
canal, thickened articular processes, subluxation of the articular processes, bone spurs 
in the articular processes, and telescoped sacral lamina 139. Quantitative phenotyping of 
LS using canal area measurements in large dogs of multiple breeds have also been 
previously reported and correlated with clinical cauda equina syndrome 112. However, 
unless a dog presents with clinical signs of pain or discomfort, expensive imaging 
studies such as CT are not routinely performed and the condition can go undetected 
until the damage is irreversible. Therapeutic interventions are more effective in younger 
military working dogs with LS and mild clinical signs, and more likely to achieve a 
successful return to active duty status 16,187. In humans, CT is an established technique 
for qualitative and quantitative “deep phenotyping” of structural abnormalities before 
they cause clinical disease. Examples include valvular calcification and aortic stenosis 
in heart valve disease 203, airway obstruction and parenchymal destruction in chronic 
obstructive pulmonary disease or COPD 113, emphysema 204 205 and bone density 
abnormalities in cystic fibrosis 206. Computed tomography has also been used for 
qualitative phenotyping and making in vivo measurements of bones in experimental 
mouse models 207.  
 
An improved understanding of the genetic mechanisms underlying LS would also be 
highly beneficial for reducing the risks of early retirement in working dogs. Similar to the 
orthologous human condition of lumbar spinal stenosis (LSS), canine LS has two 
distinct etiologies: either congenital (idiopathic and developmental) or the more common 
acquired (degenerative and post-traumatic) 17. Studies have reported association 
between genetic polymorphisms in collagen genes (COL9A2 and COL11A2) and 
degenerative LSS in humans 20 21. Developmental human LSS is usually observed in 
individuals affected by achondroplasia 93, and has known genetic causes 208. Canine LS 
studies have also suggested that LS might have genetic influences that can manifest 
itself at an early age 9  11. This genetic predisposition has been predominantly 




abnormally formed vertebra usually between the last lumbar and first sacral vertebra 12 
13. Presence of LTV can often cause CES due to abnormally narrow spinal canal (LS) 
10. However no genomic exploration studies investigating the genetics of LS in Labrador 
retrievers could be found at the time of manuscript preparation. 
 
Genetic variation is the most common factor underlying most disorders – for both 
Mendelian and non-Mendelian (complex) disorders 209. In fact, of all known Mendelian 
disorders that have been studied and the causes identified (around 2,600), 
approximately 85% are due to mutations in the coding region or the “exome” 210. 
Genome wide association studies (or GWAS) have been the most widely used 
approach to study the complex disorders 211.  However, most GWAS, even the large 
scale ones, have been unable to explain the entire contribution of genes to most 
diseases 212, and often the most significant variant detected is not always the actual 
causative locus 213. The underlying reason for this limitation is that even though GWAS 
can detect multiple genes in most complex diseases, it cannot account for the 
interaction of the multiple genes with each other and with the environment 214. 
Furthermore, each of the identified risk alleles in most complex disorders usually has 
small effects 215 216, suggesting the presence of other rare variants with relatively larger 
effects 217 218. Theoretically, including the full sequence data and increasing the sample 
size should overcome this limitation, but the process would be computationally and 
statistically complicated 213. Another disadvantage of GWAS is the requirement of large 
sample sizes, a factor that can be a disadvantage in exploratory studies – both due to 
cost and logistics. Whole exome sequencing (WES) is a better alternative approach for 
exploring the underlying genetic mechanisms of both Mendelian disorders and complex 
multi-factorial diseases 219 220 216. Since coding regions constitute approximately 1% of 
the whole genome, WES is an efficient, cost-effective and sensitive method for 
exploring the genetics of a complex disorder. Another factor to consider when designing 
a study, the analysis of variations in the non-coding region of the genome is mostly 
beyond the grasp of current genetic tools available to researchers. Some of the 




223; hereditary myopathy in respiratory failure 224; osteogenesis imperfecta and Marfan’s 
syndrome 225. The ready availability of relatively inexpensive (compared to whole 
genome sequencing) off-the-shelf human exome-capture platforms also aids the entire 
process in exploratory studies. Due to homology between the human and other 
mammalian genomes (mouse, rat, dogs, cows to name a few), the human kits can also 
be used to study the exomes of other species as well.  
 
In this prospective exploratory study, our objective was to explore the canine exome to 
identify possible variants that might be associated with LS in a sample cross-sectional 
population of MWD Labrador retrievers. Computed tomography imaging was used to 
phenotype LS, and genotyping of LS was done by whole exome sequencing using a 
commercially available platform (Nextera Rapid Exome Capture kit, Illumina, San Diego, 
CA). Additionally, candidate genes from human LSS studies were also investigated to 








IV.2: Materials and Methods 
Subjects 
Forty Labrador retriever military working dogs (MWDs) were prospectively selected from 
the MWD population housed at the US Air Force Base in Lackland AFB San Antonio, 
TX. Presence during the time of data collection (from July 8, 2013 to July 13, 2013) was 
one of the selection criteria. The other criterion for inclusion in the study, besides the 
breed and physical presence, was the age of the dog – the dog had to be between 1 
and 5 years of age. Attempts were made to ensure an approximately equal number of 
males and females, as well as an approximately equal number of yellow and black 
colored dogs. The dogs had to be available for CT scanning and physical examination. 
The study had necessary IACUC approval from both the Behavioral Medicine and MWD 
Studies Department of US Armed Forces Research Office (Department of Defense 
Military Working Dog Veterinary Services or DODMWDVS) and the West Virginia 
University Research Office. 
Data recorded 
All data were collected by a single individual (JJ) with the help of personnel at the 
Holland Military Working Dog Hospital (Lackland AFB, San Antonio, TX). The 
demographic data collected included dog name and ID number, age, gender, 
breeder/vendor (if available) and dog duty status.  
 
After selection for the study, each dog was brought to the military working dog hospital 
(within the premises of the Lackland AFB) by the handler to be examined by an 
experienced veterinarian for ruling out any medical concerns with sedation. The 
veterinarian performed a complete physical examination for each dog and recorded dog 
coat color and presence or absence of each of the following clinical signs: reaction to 
palpation of the LS junction, reaction to elevation of the tail, or reaction to extension of 
the hip joints. The veterinarian interviewed the dog’s handler and other technical staff to 
record approximate times the dog spent performing tasks such as jumping up onto or 




history of reluctance to perform working tasks was also recorded.  When available, the 
dog’s pedigree was also recorded. 
 
Using a 3cc syringe and either a 22 or 20-gauge needle, blood was drawn from the 
cephalic vein of each dog and collected on commercially available sample collection 
cards (Whatman™ FTA™ cards, GE Healthcare UK Limited, Buckinghamshire, UK). 
Care was taken to ensure that the card was not saturated with blood to reduce the loss 
of efficiency during downstream DNA extraction process, also to decrease the time 
necessary for complete drying of the blood sample in the initial collection phase. After 
the cards were completely dry (approximately one hour as per the manufacturer's 
instructions), they were inserted in specially designed and labeled protective pouches 
for uncontaminated (both bacterial and fungal) transport of the samples. Care was also 
taken to avoid cross contamination between cards. The FTA™ cards were then stored 
in airtight boxes at room temperature, in a dry location, and out of direct sunlight to 
prevent mold growth and degradation of the genetic material. 
 
Dogs were sedated using the hospital’s standard sedation protocols and the CT 
scanner (Lightspeed, GE Medical Systems, Pewaukee, WI) present within the hospital 
premises was used to collect trans-axial scans of the lumbar and lumbosacral spine (L4 
caudal – S1 cranial vertebrae).  The following technical settings were used: axial mode, 
0.625 mm slice thickness, 120 kVp, 100 mA, body filter, and bone convolution kernel.   
For each scan, dogs were positioned in dorsal recumbency.  Scans were acquired with 
the rear limbs first placed in a maximally extended position and then repeated with the 
rear limbs placed in a maximally flexed position.  The hospital’s CT technologist under 
the supervision of a licensed veterinarian completed all positioning and scanning 
procedures.  A standardized protocol for positioning was provided to the technologist to 






Qualitative CT phenotyping was done for all 40 dogs in 8 vertebral locations, 
encompassing the cranial and caudal ends of 4 lumbar (L4, L5, L6 and L7) and 1 sacral 
(S1) vertebra – L4 caudal, L5 cranial, L5 caudal, L6 cranial, L6 caudal, L7 cranial, L7 
caudal, and S1 cranial. Using standard criteria for CT radiological diagnosis of LS in 
dogs, a single licensed veterinary radiologist (JJ) assigned all 40 dogs to one of two 
groups – LS negative or control (no structural stenosis found at any of the 8 locations); 
and LS positive or affected (structural stenosis observed in at least in one of the 8 
locations). In the previous phenotyping study (chapter III), we found a strong association 
between presence of qualitative structural LS and cross-sectional canal FAR (fat area 
ratio) values for the 6 vertebral locations analyzed (L5 caudal, L6 cranial, L6 caudal, L7 
cranial, L7 caudal, and S1 cranial). So the FAR values were also calculated in this 
current study for the quantitative CT phenotyping of LS in these 40 dogs (technique 
described in chapter III), but for 8 vertebral locations instead of the original six. Fat area 
ratio values for all 40 dogs were then listed in a descending order. The top ten dogs 
(highest FAR values = LS negative/control) and the bottom ten dogs (lowest FAR value 
= LS positive/affected) were selected for each of the 8 locations. The 4 dogs that 
appeared the most number of times (high frequency) in the top ten list across all 8 
locations, had the highest FAR values, and were qualitatively LS negative were selected 
to represent LS negative (control) dogs in the follow-up genetic analysis. Similarly, the 4 
dogs with the highest frequency in the bottom ten list across all 8 locations, lowest FAR 
values, and qualitatively LS positive were selected to represent LS positive (affected) 
dogs in the genetic study.  
Genotyping 
Three separate attempts were made to extract genomic DNA from the peripheral blood 
collected on commercially available sample collection cards (FTA™, GE Healthcare UK 
Limited, Buckinghamshire, UK) and analyzed with 3 different commercially available 
DNA extraction kits (using standard manufacturer recommended protocols). First: 
Whatman™ FTA™ Purification Reagent (GE Healthcare UK Limited, Buckinghamshire, 




WI). Third: GenSolve DNA Recovery Kit – GVR-110 (GenTegra LLC., Pleasanton, CA). 
The GenSolve protocol was the most successful and included an additional blood 
contamination purification step (QIAamp Blood DNA Mini Kit, QIAGEN, Hilden, 
Germany). The purified genomic DNA samples were then transported to the Core 
Genomics Facility at West Virginia University (Morgantown, WV) for sequencing and 
bioinformatic analyses. 
Exome sequencing and Bioinformatics 
A commercially available exome capture kit (Illumina Nextera Rapid Exome Capture kit, 
Illumina Inc., San Diego, CA) was used for exome enrichment and capture, followed by 
rapid exome sequencing in the commercially available bench-top sequencer (MiSeq 
System, Illumina Inc., San Diego, CA). The personnel at the WVU Genomics Core 
Facility (West Virginia University, Morgantown WV) carried out all sequencing reactions 
including the library preparations, using manufacturer recommended protocols without 
any modifications. Though the kit is designed to capture human exomes there is enough 
sequence homology between humans and dogs (Illumina application 
note http://www.illumina.com/products/nextera-rapid-capture-exome-kits.ilmn) to ensure 
a successful canine exome capture with a large coverage area. The white paper 
published by Illumina claims a success rate of 85% for canine exons with >80% 
homology with human exons, while canine exons with <80% homology had a capture 
success rate of 18%. The MiSeq sequence data were not recorded (since the 
workstation is programmed to automatically map to the human reference genome) 
instead the raw files were selected for bioinformatic analysis.  
 
The Genomic Core Facility of West Virginia University also carried out part of the 
bioinformatic analysis in this study. The quality of the raw exome reads was analyzed 
using FastQC 226; and Trimmomatic 227 was used to filter out bad reads. The retention 
criteria were: leading bases with quality higher than 25, trailing not less than 20, four 
base sliding window cutoff of 25 and reads over 50 bases long. Each sample exome 
was then mapped to the reference dog genome CanFam3.1 (Broad 




parameters); followed by variant calling using SAMtools 229 and BCFtools 230, 
respectively. SnpEff 231 was used to annotate each called variant, generating a variant 
call file (VCF). Another round of annotation was carried out to remove variants not 
called in all 8 samples, creating a second VCF file. The genomics core facility provided 
this second VCF file to the authors for further analysis (MM). A commercially available 
sequence annotation software package (Golden Helix SNP and Variation Suite, Golden 
Helix Inc., Bozeman, MT) was used to differentiate between the 4 LS negative dogs and 
the 4 LS positive dogs. The VCF file was filtered using the column selection by sample 
genotype tool of the software. Two separate selection settings were used to identify 
variants between the 2 groups – 4 LS negative or control dogs and 4 LS positive or 
affected dogs (with “a” control or reference allele; “b” is the affected or alternate allele; 
“a/a” and “b/b” = homozygous for reference and alternate alleles respectively; and “a/b” 
is heterozygous). The 1st setting was: control = “a/a”, and affected = “b/b”. And the 2nd 
setting was: control = “a/a”, and affected = “a/b” or “b/b”. The 2nd setting was designed 
to account for dogs being carriers of the condition (LS) in the heterozygous state. 
Exonic variants were identified by aligning the variant list with the canine reference 
genome 146 CanFam3.1 (September, 2011 assembly release) 232 with the University of 
California Santa Cruz (UCSC) genome browser 233 234 (http://genome.ucsc.edu/cgi-
bin/hgGateway?hgsid=491971977_8JIhYf9FMf1aywMqaevxvSn9eGbg&clade=mammal
&org=Dog&db=0). The list of variants was annotated using a variant effect predictor 
web interface (VEP, Ensembl Gene annotation v83, December 2015) 235. Since not all 
canine genes have been characterized, predicted genes were recorded (based on 
Ensembl predicted gene sets).  The National Center for Biotechnology Information 
(NCBI) Basic Local Alignment Search Tool (BLAST) 236 was used to calculate 
percentage homology for the predicted canine gene sequences with the human and 
mouse reference gene sequences. The biological significance (i.e. association with 
clinical disorders) of the identified genes reported in either NCBI 237 or Ensembl 238 





A separate analysis was done to call on any variants previously reported as human LSS 
candidate genes – genes associated with other closely related musculoskeletal 
diseases like osteoarthritis (OA), Paget’s disease, degenerative disc disease (DDD), 
ossification of posterior longitudinal ligament (OPLL), osteogenesis imperfecta (OI) and 
Ehlers Danlos syndrome (EDS). The parameters in this second analysis were the same 
as the previous analysis – the 4 control dogs were either “a/a” or “a/b”; and the 4 






The 40 Labrador retrievers selected for this study comprised of 20 males and 20 
females. Even though we set out to get equal number of black and yellow dogs, the 
study ended up with 24 black and 14 yellow dogs, and 1 chocolate colored Labrador 
retriever; the remaining single dog’s coat color record was unavailable. The average 
body weight of the study population was 28.48 kilograms (range 22.00 – 38.56 pounds). 
Based on qualitative phenotyping (CT assessment) by the board-certified radiologist 
(JJ), 33 dogs showed signs of structural stenosis in at least one of the eight vertebral 
locations and the remaining 7 dogs were free from stenosis in all 8 locations. Sixteen of 
the 40 dogs were negative for signs of LBP (in the lumbosacral region) on physical 
examination during data collection (CT scanning and blood collection). The remaining 
24 dogs did displayed equivocal signs of pain during physical examination. The study 
subject demographics are described in Table IV.1. 
 
The 8 dogs selected from aforementioned 40 dogs for whole exome sequencing (WES) 
had individuals representing the entire age range of the study i.e. 1 to 5 years. The 4 
most LS negative dogs were all females and aged between 1 and 3 years. Three of the 
LS negative dogs were related to each other – one dam and two offsprings. The 4 most 
LS positive dogs were all males and aged between 3 and 5. There was poor agreement 
between LBP status and qualitative assessment of stenosis. Only one out of the 4 LS 
negative dogs was negative for signs of LBP, while only two of the 4 LS positive dogs 
showed signs of LBP. The demographic data of the 8 dogs selected for WES are 
described in Table IV.3.  
 
Phenotyping 
The 8 dogs were selected for exome sequencing based on both fat area ratio (FAR) 
values as well as qualitative criteria for LS. The maximum and minimum FAR values at 




4 LS positive dogs) selected to depict the extremes of the phenotype of LS after first 
round of selection (but genetic samples lost) are presented in Table IV.2.A. The 
maximum and minimum FAR values at each of the 8 vertebral locations for the 8 dogs 
selected for exome sequencing to represent the extremes of phenotype after second 
round of selection are shown in Table IV.2.B. In the 8 dogs selected in first round, the 
smallest FAR values for the LS negative dogs was larger than the highest FAR values 
of LS positive dogs at 7 of the 8 vertebral locations. In the 8 dogs from the second 
round of selection (whole exome sequencing samples), the lowest FAR values in the LS 
negative dogs was also larger than the highest FAR values of the LS positive dogs, but 
in 5 of the 8 locations (instead of the 7 in 1st round of selected dogs). Dogs selected in 
both rounds as either LS negative or LS positive had agreement with the qualitative CT 
diagnosis of LS.  
 
Genotyping 
The Nextera Rapid Exome Capture kit requires a minimum concentration of 5-ng/µl 
DNA in a final volume of 10-µl (50 ng total). The first method of extracting genomic DNA 
from blood on FTA™ cards using FTA™ purification reagent was mostly unsuccessful in 
yielding any usable DNA. The second method using Promega Wizard SV Genomic DNA 
extraction kit (using standard manufacturer recommended protocol) did yield some 
DNA, but the quality was compromised by blood contamination and insufficient quantity 
for high resolution downstream sequencing reactions. An unfortunate outcome from this 
second method attempt was the loss of samples from the 8 dogs that best met the 
selection criteria. A second round of phenotyping selection was done to get the next 
best 8 dogs (4 LS negative and 4 LS positive) that also met the selection criteria. The 
third method using GenSolve DNA Recovery kit had the best performance of the 3 
methods at yielding DNA of sufficient quality and quantity needed for sequencing 
reactions. The genomic DNA yield from this method (for all 8 samples) ranged between 
11.9 and 13.2 ng/µl suspended in a final solution volume of 100 µl AE buffer (QIAGEN, 
Hilden, Germany) – thus more than meeting the minimum requirements of the exome 





Exome Sequencing and Bioinformatics 
The sequencing runs for all 8 dogs (4 LS negative and 4 LS positive) resulted in fairly 
even representation among samples. After eliminating poor-quality raw exome reads, 
alignment with the reference canine genome (Broad CanFam3.1/canFam3 Assembly, 
September 2011) gave a good alignment value (95+%). The VCF file provided by the 
Genomics Core Facility included 110, 980 variants (variants called in all 8 samples). Out 
of these 110,980 variants, 439 had to be excluded because they could not be assigned 
to any known canine chromosome number. Golden Helix SVS was used to analyze the 
remaining 110,541 variants. No exonic variants matching the 1st sample genotype 
setting i.e. LS negative (“a/a”) vs. LS positive (“b/b”). The 2nd sample genotype setting 
detected 252 variants, i.e. LS negative dogs (“a/a”) vs. LS positive (“a/b” or “b/b”).  
 
Manual curation identified 82 exonic variants (out of 252). These 82 exonic variants 
encompassed a total of 33 genes (both annotated and predicted) and the data are 
represented in Table IV.4. The predicted genes along with their percentage homology 
with the orthologous human and mouse genes are reported in Table IV.5. The list of 252 
variants was also annotated using VEP tool of Ensembl. Twenty-three of the 252 
variants did not parse by VEP so could not be analyzed. Out of the 229 variants 
analyzed, 165 (72.1%) were novel. All possible consequences of the 229 analyzed 
variants are summarized in Figure IV.1. Out of all the variants detected that were 
present in coding regions, majority (80%) were synonymous mutations, and the 
remaining 20% were missense mutations as depicted in Figure IV.2. VEP was unable to 
identify any high impact variants (disruptive like protein truncation, loss-of-function or 
triggering nonsense mediated protein decay); but it was able to identify some moderate 
impact variants (non-disruptive that might change protein effectiveness) encompassing 
10 genes (both annotated and predicted). The variants detected by VEP and assigned 
as having moderate impact are listed in Table IV.6.. Since not all canine genes have 
been annotated yet, there are some genes in the list with no known gene symbol, 




generated manually. The VEP was also able to identify several low impact variants 
(assumed to be mostly harmless and/or unlikely to influence protein behavior) spanning 
a total of 24 genes (also identified by manual curation, see Table IV.5). Thus VEP was 
able to identify one more gene (10 + 24 = 34) than the list of genes identified manually 
(33). Impact assessment was not possible in the manual method. 
 
Functions and biological significances (previously reported associations with clinical 
syndromes) of the 33 genes that contain the 82 exonic variants (and matches the 
sample genotype parameters) are reported in Table IV.7. Of the 10 genes with variants 
having moderate impact (as identified by VEP), one gene could possibly have an 
association with LS in Labrador retrievers – Transthyretin (TTR). A missense mutation 
(preserved protein length but with a different amino acid) was detected in TTR gene. 
Recent studies have reported that TTR-derived amyloidosis might have an association 
with Senile Systemic Amyloidosis (SSA) in humans 239, a condition where amyloid 
protein deposits can be found on musculoskeletal connective tissues, usually also 
accompanied by LSS (lumbar spinal stenosis) and cardiomyopathy. Among the 24 
genes identified by VEP as having variants with low impact, two genes could also have 
some association with LS in Labrador retrievers: Folate Receptor 2 (FOLR2), and 
Ubiquitin Specific Peptidase 9 X-linked (USP9X). Folate Receptor 2 or beta has been 
known to be associated with osteoarthritis (OA) 240, and association between OA and 
LSS in humans is well documented. USP9X is an X-linked gene that escapes X-
inactivation in mammalian females 241, so females contain twice the dose of this gene 
product as males. The sex-specific trend of LS in dogs (males are affected almost twice 
as females, according to some reports) could mean that LS is an X-linked condition, and 
USP9X gene product doses being different between males and females could be 
playing a role in LS disease pathology. The positions of the candidate genes (from 
human LSS studies) in the canine genome (Broad CanFam3.1/canFam3 Assembly, 
September 2011) are represented in Table IV.8. No exonic variants were detected in 







To the best of our knowledge, this is the only study that has investigated the genetics of 
lumbosacral stenosis (LS) in Labrador retrievers. Lumbosacral stenosis is the most 
common lumbosacral spinal disease affecting large breed dogs like German shepherds 
and Labrador retrievers. Even though German shepherds is the breed in which LS has 
been reported the most, most of these studies have also reported the Labrador 
retrievers as another affected breed (often as a close second according to recorded 
frequencies). There are several studies that have focused on LS in German shepherds, 
but as far as we know no other group is actively studying LS in Labrador retrievers – 
another high-risk breed for LS. And with respect to genetic association studies of LS in 
dogs, none have been reported in any breed (as of the time of this manuscript 
preparation). Since LS is a naturally occurring disease in both Labrador retrievers and 
German shepherds, either of the 2 breeds could be a viable model for canine LS, but 
the growing popularity and vast numbers of Labrador retrievers found in the United 
States, not only as household pets but also as working dogs (especially detection 
military working dogs or MWDs), makes Labrador retrievers a popular choice for LS 
studies. 
 
To make the most of the whole exome sequencing (WES) study, the first strategy is to 
select the optimum study subjects – usually ones representing the extremes of the 
phenotype being investigated 242. With this approach, even a low number of study 
subjects can yield usable data. Military working dogs are selected and trained to be 
high-performance athletes. There exists a theory in human medicine that a physically 
strenuous and active life (like that led by athletes) can result in premature degeneration 
of the musculoskeletal system, which in turn can lead to early appearance of 
degenerative diseases – like LS. However there is little scientific evidence to back this 
statement. A similar theory also exists in canine medicine – and again there is a lack of 
scientific evidence to support it. Future studies investigating the effects of strenuous 




canine athletes. Military working dogs would be a desirable study population for this 
research. In the current study, advantages of using MWD Labrador retrievers from a 
single military base (Lackland AFB, TX) as the study subjects were: (i) all dogs in the 
study were present at the same physical location making the logistics of data collection 
simple; (iii) all the dogs had a highly uniform lifestyle – same diet, same exercise 
regimen, same healthcare opportunities (Holland Military Working Dog Hospital present 
inside the military base premises), same living conditions, and all dogs are maintained 
at a high level of physical fitness ensuring  – thereby ruling out several possible sources 
of external environmental variation that might have influenced the genetic association 
results; and (iii) the availability of the in-house CT scanner made the acquiring of CT 
scans for the phenotyping part of the study a much more feasible process. 
Disadvantages of using this sample population were that results might not be 
generalizable for other breeds and other types of work. Another limitation of this 
population is the absence of pedigree records for majority of the dogs due to 
procurement from a variety of vendors. This particular method of acquiring MWDs is 
common. In future studies more pro-active methods of selection of MWDs would be 
desirable. 
 
However, the presence of the study subjects inside a secure military base also led to 
the logistical problem – DNA could not be isolated on-site, samples had to be collected 
on site and then safely transported with viable DNA for genetic analysis at a later date. 
Even though fresh blood in EDTA gives the best DNA yield, transportation would have 
posed a problem, and the samples would have to be processed as soon as possible 
(blood in EDTA does not have a long shelf life with or without refrigeration). Therein 
came the advantage of using Whatman™ FTA™ (Flinders Technology Associate) cards 
– a relatively inexpensive medium for collecting biological samples (saliva, cell cultures, 
plant extracts, blood etc.), that can be stored for extended periods of time (sometimes 
up to decades), while preserving the genetic material for future genetic analyses 
(protected from external factors like environment and microbial contamination). The 




methods (blood in EDTA tubes). FTA™ cards are common practice in collecting genetic 
material in agricultural settings, including plants and animals like cows (Hu, 2010 #680), 
horses 243, and dogs 244 – especially in situations where in field laboratory setup is 
unavailable, or there is need for transportation and storage of samples without 
refrigeration. This feature of FTA™ cards allowed us to extract viable DNA (sufficient 
quality and quantity for sequencing study) 2 years after data collection – samples were 
collected in 2013, and DNA was extracted in 2015). So FTA™ cards can be a viable 
method for collection of genetic material from MWDs, especially because of the 
unpredictability of their location at any given point of time. In fact, FTA™ cards have 
already been in use in the US military for collecting DNA from human soldiers (for 
identification purposes). FTA™ cards can easily transition to benefit the health and 
welfare of the canine soldiers by collecting their genetic material not only for 
identification purposes but also for medical testing.  We do acknowledge the fact that 
the amount of DNA extractable from these cards is not as high as one might get from 
fresh blood in EDTA tubes or buccal swabs (standard practices in canine genetic 
research), but situations in which transport and storage of the genetic material are of 
concern, FTA™ cards could be the solution. FTA™ cards could also provide a unique 
opportunity to perform longitudinal studies.  
 
The Yao lab at WVU already uses the Promega Wizard SV Genomic DNA recovery kit 
for DNA extractions needed for their ongoing projects in aquaculture and reproductive 
physiology. The ready availability of this kit inspired the attempt of extracting DNA from 
FTA™ cards using this method. The DNA yield was decent (average yield of 25 
nanogram per microliter in 50 microliters suspension), but the blood contamination was 
also quite high (often visible as a reddish hue in solution). We attempted to purify the 
DNA with ethanol purification and DNA purification kits, but that resulted in loss of 
usable DNA volume. So we propose that the Promega kit can be used to extract DNA 
for basic PCR reactions but if the end-goal is sensitive sequencing reactions, then 
Promega Wizard SV Genomic DNA Recovery kit is probably not the best approach for 




purification step to remove blood contaminants. GenTegra GenSolve kit gave us better 
yield of DNA from blood on FTA™ cards. However, a major limitation of this study was 
the loss of DNA from the best 8 candidate dogs during initial DNA isolation phase. It 
would be beneficial to do a follow-up study in a larger population of true LS negative 
and LS positive Labrador retrievers to test the validity of FTA cards as a workable 
medium for collection of canine genetic material and GenTegra GenSolve kit’s ability to 
extract the canine genetic material out of the FTA cards.  
 
The 40 dogs in the study comprised of equal number of males and females, and the LS 
positive group was made up of 17 males and 16 females. Selection of dogs for exome 
sequencing to represent the extremes of the phenotype (LS positive or LS negative) 
was blinded. The dogs selected comprised of 4 affected males (LS positive) and 4 
unaffected females (LS negative). This all male and all female selection was 
coincidental. Previous human LSS and canine LS studies have reported a higher 
incidence in males than in females. Possible reasons suggested include faster growth 
rate of males, larger body weight and more popular choice as working dogs 123 189 245 
122. It is important to note that 3 of the LS negative dogs were related to each other and 
this could be a possible source of bias in the results. Complete pedigree information for 
all 40 dogs in the study was not available, so pedigree analysis was not possible. A 
future study investigating the pedigree structure of these dogs could yield valuable 
insight into prevalence of LS within the MWD population.  
 
Low back pain (recorded as part of the physical examination during data collection) and 
LS status (recorded based on veterinary radiologist diagnosis) of the dogs included in 
this study did not agree consistently. This was in agreement with previous reports in 
MWDs 187 16. Only 1 of the 7 LS negative dogs (14.3%) was LBP negative, the other 6 
(85.7%) showed signs of pain despite being negative for stenosis (according to CT 
findings). Of the 33 dogs that were designated LS positive (in at least one vertebral 
location), 18 dogs (54.5%) were LBP positive, however there were 15 dogs (45.5%) that 




discrepancy could be the fact that these dogs are selected and bred for stoicism and 
high working drive. Therefore some dogs with LS could have been masking their clinical 
signs. Another possible reason for the discrepancy could be that LBP might have been 
caused by other clinical problems besides LS like degenerative sacroiliac joint disease 
(DSJD) 132, foraminal stenosis 133 and Schmorl’s nodes 134. This high-drive personality 
makes this breed an excellent candidate for working dogs, but can also be 
disadvantageous in early detection of LS based on signs of LBP alone since the same 
trait that makes them good working dogs, also makes them good maskers of pain.  
 
Age is usually considered to be a factor in degenerative LS, however in this study as a 
whole constituted of only young dogs, both groups (LS negative and LS positive) had 
representation from all ages (1 to 5). The appearance of LS at such relatively young 
ages could signal a different etiology of LS in this population of dogs i.e. MWDs. Since 
these dogs are too young to acquire degenerative changes in their bodies (despite the 
nature of their lifestyle), the type of LS affecting these MWDs could be idiopathic.  
 
The FAR values in all LS negative dogs were consistently higher than the FAR values in 
LS positive dogs. The minimum FAR values for the LS negative group for 5 of the 8 
locations were higher than the maximum FAR values in the LS positive group (L5 
cranial and caudal; L6 cranial; L7 cranial and caudal). This further supports the results 
from previous study (chapter III) – that fat area ratio (FAR) is a viable tool to 
quantitatively phenotype LS in Labrador retrievers. Studies need to be conducted to test 
the validity of FAR as a measure of LS not only in a larger sample of Labrador 
retrievers, but also in other breeds of dogs and maybe in humans as well. 
 
Even though WES usually involves small sample size, our sample size of eight 
individuals was too small to allow robust statistical analyses. Future studies with larger 
sample sizes are needed that would increase the power of statistical analyses. Also at 
the time this study was planned and conducted, there was no dedicated canine exome 




specific to the canine genome has been developed (Roche NimbleGen, Madison, WI). 
Future analyses using this species-specific kit would be desirable to improve the 
sensitivity of future canine WES studies in identifying genetic variants underlying LS.  
 
Out of all the variants identified between the control and affected groups from the 
exome sequencing data, only 252 variants met the criteria that accounted for either 
asymptomatic or carriers. The study was unable to find any variants where the 
relationship between variants and phenotype was more straightforward without the need 
for making allowance for carriers/asymptomatic samples. Variant Effect Predictor was 
unable to find any variants with high impact and it could not annotate all the variants to 
specific predicted genes. VEP was able to identify variants with moderate impact (10 
genes) and low impact (24 genes). Manual curating of the VCF file using Golden Helix 
SVS software was able to assign 82 of the 252 variants to exons of 33 protein-coding 
genes (NCBI and Ensembl). Of the 33 genes, 3 genes could have possible associations 
with LS in Labrador retrievers – Transthyretin (TTR), Folate Receptor 2 (FOLR2) and 
Ubiquitin Specific Peptidase 9, X-linked (USP9X).  
 
First, TTR – recent studies have reported that TTR-derived amyloidosis might have an 
association with SSA (senile systemic amyloidosis) – a group of disorders involving the 
localized deposition of amyloid proteins in a variety of tissues 246. A 2011 study found an 
association between senile systemic amyloidosis and lumbar spinal stenosis in the 
Japanese population 247. This study examined ligamentum flavum specimens from 36 
individuals with confirmed cases of LSS. Nineteen of the 36 samples tested positive for 
amyloid protein deposits. There are at least 30 different types of amyloid proteins that 
can be deposited in the human body 248. Transthyretin-derived amyloidosis (ATTR) is 
one such condition and 16 of those 19 specimens with SSA that tested positive for 
amyloid deposits, had ATTR. Another recent study has also found an association 
between transthyretin-derived amyloidosis in SSA and LSS within the Swedish 
population 239. This study comprised of resected material (bone fragments, pieces of 




spinal stenosis (the only inclusion criterion). Amyloid deposits were detected in 25 of the 
26 samples. Deposits of amyloid protein in the brain have been well investigated for 
several years because of the role it plays in Alzheimer’s disease and Down’s syndrome 
249. Amyloid deposits are also commonly found in connective tissues like ligaments, 
tendons and cartilages especially in the joints (knee, hip, vertebrae) of elderly 
individuals 250 251 252; but the biological significance of this type of amyloidosis is 
unknown 239. Similar to the amyloidosis seen in Alzheimer’s disease (brain tissue), 
ATTR deposits (connective tissue/skeletal tissue/neural tissue) are also believed to be 
aging-related and are usually observed in individuals older than 60 years of age. 
Transthyretin-derived amyloidosis has a higher rate of incidence in males when 
compared to females; and is usually accompanied by cardiomyopathy and carpal tunnel 
syndrome as clinical complications. All these factors imply that LSS could be a 
consequence of SSA, making the transthyretin (TTR) gene a good candidate gene for 
future studies of LSS in humans, and maybe TTR could also be associated with LS in 
Labrador retrievers. Second, FOLR2 has been found in macrophages present in the 
synovial fluid of patients suffering from osteoarthritis (OA) 240. And lastly, USP9X is an 
X-linked gene that escapes X-inactivation in mammalian females 241, so females have 
twice the dose of this gene product as males. The sex-specific trend of LS in dogs 
(males are affected almost twice as females, according to some reports) could mean 
that LS is an X-linked condition, and USP9X gene product could be playing a protective 
role in LS disease pathology, and is the cause for the difference in incidence rate 
observed between males and females Despite these findings, it is important to note that 
these are just conjectures at this point, future studies investigating these “new candidate 
genes”, especially TTR, are needed to delineate the true relationship between these 3 
genes and LS in Labrador retrievers.  
 
Another important aspect of the results in this study was the absence of any exonic 
variants within human LSS candidate genes. The sample size of this study was too low 
to rule out the involvement of these human LSS candidate genes altogether, so further 




true relationship between canine LS and human LSS candidate genes. Also the genetic 
findings in this study could be specific for idiopathic LS and not degenerative LS. The 
candidate genes from human LSS studies (mostly degenerative kind) could be shared 




































CT – computed tomography LS – lumbosacral stenosis 
M – male F – female 
W – working NW – non-working 
  
Group CT LS negative CT LS positive 
Number 7 33 
Average Age 2.57 (± 0.45) 2.88 (± 0.22) 
Sex 3 M, 4 F 17 M, 16 F 
Average Weight 25.80 (± 1.35) 29.05 (± 0.72) 
Weight Range 22.50 - 32.66 22.00 - 38.56 




Table IV.2.A. Maximum and minimum fat area ratio values for 8 vertebral locations 
among the 8 dogs selected to represent the extremes of the phenotype – 1st 
round of selection (samples lost) 
 
Vertebral location 
LS negative LS positive 
Max Min Max Min 
L4Cd 0.174 0.113 0.115 0.029 
L5Cr ^ 0.183 0.075 0.061 0.028 
L5Cd ^ 0.307 0.218 0.155 0.088 
L6Cr ^ 0.169 0.148 0.120 0.058 
L6Cd ^ 0.373 0.297 0.202 0.140 
L7Cr ^ 0.205 0.128 0.109 0.065 
L7Cd ^ 0.379 0.294 0.230 0.199 
S1Cr ^ 0.195 0.144 0.091 0.044 
 
 
Table IV.2.A. Maximum and minimum Fat Area Ratio (FAR) values for all of the 8 
vertebral locations within the 2 groups of 4 dogs each (LS negative and LS positive).  
^ Denotes vertebral locations where the lowest FAR value in LS negative (control) dog 






Table IV.2.B. Maximum and minimum fat area ratio values for 8 vertebral locations 
among the 8 dogs selected to represent extremes of the phenotype – 2nd round of 
selection (whole exome sequenced samples) 
 
Vertebral location 
LS negative LS positive 
Max Min Max Min 
L4Cd 0.115 0.074 0.099 0.038 
L5Cr ^ 0.140 0.088 0.056 0.029 
L5Cd ^ 0.268 0.215 0.162 0.099 
L6Cr ^ 0.162 0.143 0.089 0.067 
L6Cd 0.294 0.233 0.251 0.189 
L7Cr ^ 0.162 0.142 0.091 0.052 
L7Cd ^ 0.338 0.264 0.262 0.207 
S1Cr 0.173 0.136 0.166 0.077 
 
 
Table IV.2.B. Maximum and minimum Fat Area Ratio (FAR) values for all of the 8 
vertebral locations within the 2 groups of 4 dogs each (LS negative and LS positive).  
^ Denotes vertebral locations where the lowest FAR value in LS negative (control) dog 






Table IV.3. Demographic data of the 8 dogs selected for exome sequencing 
 
Characteristic LS negative LS positive 
Age 1, 1, 2, 3 3, 4, 4, 5 
Sex 4 F 4 M 
Mean weight 24.05 31.75 
LBP status 3 Y, 1 N 2 Y, 2 N 
Coat color 3 BL, 1 YL 3 BL, 1 YL 
Work status 2 BR, 2 IT* 2 IT, 1 TA, 1 HH^ 
 
* - Former breeders (BR) that were spayed and placed in training (IT)  
^ - Detection dog but put in hospital hold for T. cruzi infection  
 
 Legend:  
   
Breeder BR Female F 
In-training IT Male M 
Training aide TA Yes Y 
Hospital hold HH No N 




Table IV.4. List of single nucleotide variants present within the canine exome and 
the genes that the exons correspond to as detected by manual curating  
 











1 1 89360055 DOCK8 T C 
2 1 118921713 SLC7A10 C T 
3 1 119322126 RGS9BP C(G) T(A) 
4 1 120453353 TSHZ3 C T 
5 4 20145950 KIF1BP  G A 
6 6 9069346 TFR2 C T 
7 7 2203010 KIF21B C T 
8 7 10364384 DTL G A 
9 7 56104696 ASXL3 T(A) C(G) 
10 7 56104802 ASXL3 G(C)  T(A) 
11 7 56106097 ASXL3 C(G) T(A) 
12 7 57689546 TRAPPC8 C T 
13 7 57946958 TTR T(A) C(G) 
14 8 4065167 LRRC16B G A 
15 8 50655038 ADCK1 C T 
16 10 69081780 ADD2 C(G) T(A) 
17 11 24735565 SPOCK1 G (C)  A(T) 
18 13 22573204 RNF139 A G 
19 13 22573204 TATDN1 A(T) G(C ) 
20 14 26883347 EEF1A1 G A 
21 14 26883912 EEF1A1 G A 
22 14 31311638 AGR2 G(C ) A(T) 
23 14 36176692 DNAJA1 A(T) G(C ) 
24 14 36176713 DNAJA1 A(T) G(C ) 
25 14 52320547 TMEM168 G(C ) A(T) 
26 15 61421904 CPE T G 
27 17 8320429 GREB1 A G 




29 20 39607968 BSN G(C ) A(T) 
30 20 45454325 ABHD8 T C 
31 21 25954898 FOLR2 T(A) C(G) 
32 25 19512970 PALLD T C 
33 25 19513039 PALLD C T 
34 27 25335426 ABCC9 C T 
35 27 31190558 PTPRO T(A) C(G) 
36 32 17161549 SMARCAD1 T A 
37 34 32184660 ZBBX A(T) T(A) 
38 34 32184727 ZBBX T(A) C(G) 
39 X 19788051 ZFX A C 
40 X 19788059 ZFX C A 
41 X 19788111 ZFX C T 
42 X 19788144 ZFX G A 
43 X 19789071 ZFX G A 
44 X 19789132 ZFX A T 
45 X 19789173 ZFX C A 
46 X 19789176 ZFX C T 
47 X 19789317 ZFX A G 
48 X 19789321 ZFX G A 
49 X 19789401 ZFX C T 
50 X 19789437 ZFX C T 
51 X 19789440 ZFX C T 
52 X 19789458 ZFX A G 
53 X 19789494 ZFX G C 
54 X 19789503 ZFX G A 
55 X 19789515 ZFX G A 
56 X 19789551 ZFX G A 
57 X 19789563 ZFX A G 
58 X 19789569 ZFX T C 
59 X 19789651 ZFX C G 
60 X 19789653 ZFX T C 
61 X 19789689 ZFX C T 
62 X 19789692 ZFX C T 





















Table IV.4. List of 82 exonic variants matching sample genotype parameters (as 
detected by manual curation)  
Also listed are the positions of the variants in the canine genome, the gene symbols 
they correspond to, and the sequence variation. Instances where the gene is read in the 
reverse, parentheses were used to denote the sequence of the sense strand and the 
sequence outside of the parentheses the sequence of the reverse strand. The 82 exonic 
variants encompass a total of 33 genes. 
  
64 X 19789740 ZFX G A 
65 X 19789749 ZFX G A 
66 X 19789803 ZFX T C 
67 X 19789818 ZFX C T 
68 X 19789839 ZFX A G 
69 X 19789906 ZFX C T 
70 X 19789908 ZFX C G 
71 X 19789914 ZFX C T 
72 X 19790001 ZFX C T 
73 X 19790028 ZFX G A 
74 X 19790031 ZFX C T 
75 X 19790040 ZFX T C 
76 X 19790091 ZFX A G 
77 X 19790106 ZFX C T 
78 X 19790136 ZFX T G 
79 X 19790197 ZFX C T 
80 X 19790207 ZFX A G 
81 X 35651733 USP9X G (C)  A (T) 




Table IV.5. List of canine genes with exonic single nucleotide variants and their 
percentage homology with human and mouse orthologues 
 
 
















1 1 DOCK8 9 93 2 e^-90 19 88 2 e^-70 
2 1 SLC7A10 19 93 1 e^-74 7 91 1 e^-69 
3 1 RGS9BP* 19 81 1 e^-167 7 76 4 e^-98 
4 1 TSHZ3 19 91 0 7 87 0 
5 4 KIAA1279 a.k.a. KIF1BP 10 88 0 10 81 0 
6 6 TFR2 7 88 5 e^-52 5 87 4 e^-37 
7 7 KIF21B 1 76 2 e^-173 1 91 7 e^-79 
8 7 DTL 1 92 0 1 85 0 
9 7 ASXL3* 18 87 0 18 81 0 
10 7 TRAPPC8 18 90 0 18 81 0 
11 7 TTR* 18 94 4 e^-24 18 NA NA 
12 8 LRRC16B* 14 90 3 e^-109 14 89 8 e^-109 
13 8 ADCK1 14 93 1 e^-75 12 92 2 e^-74 
14 10 ADD2 a.k.a. ADDB 2 84 3 e^-133 6 93 6 e^-55 
15 11 SPOCK1 5 91 2 e^-139 13 90 3 e^-72 
16 13 RNF139 8 92 0 15 91 0 
17 13 TATDN1 8 86 1 e^-48 15 88 0 
18 14  EEF1A1** 6 88 0 9 86 0 
19 14 AGR2 7 85 2 e^-32 12 92 3 e^-19 
20 14 DNAJA1** 9 89 0 4 89 0 
21 14 TMEM168 7 81 0 6 88 0 
22 15 CPE 4 82 0 9 88 3 e^-6 
23 17 GREB1 or KIAA0575 2 86 0 12 79 3 e^-109 
24 20 BSN or ZNF231 3 88 0 9 84 0 
25 20 ABHD8 19 87 0 8 90 2 e^-53 
26 21 FOLR2 or FBP 11 94 1 e^-73 7 81 2 e^-26 
27 25 PALLD 4 84 0 8 80 3 e^-86 




29 27 PTPRO* 12 78 0 6 91 2 e^-41 
30 32 SMARCAD1 4 92 0 6 82 0 
31 34 ZBBX* 3 84 2 e^-78 3 80 2 e^-42 
32 X ZFX** X 91 0 X 85 0 
33 X USP9X X 93 0 X 86 0 
 
Table IV.5. List of 33 genes with exonic variants between LS negative (control) and LS 
positive (affected) Labrador retrievers 
Also listed are the percentage homology between the predicted genes (according to 
Ensembl database) and the human and mouse orthologues  
 
*  – Genes annotated by VEP as carrying moderate impact variants 
** – Genes identified by VEP as carrying moderate impact variants but not annotated 





Table IV.6. Variants with moderate impact as detected by Ensembl’s Variant Effect 
Predictor (VEP)  
 
Table IV.6. List of moderate impact variants detected by VEP (i.e. non-disruptive 
capable of changing protein effectiveness) 
Also listed are the chromosome number, position, variant allele, name and annotation of 
the gene that the exon is part of and the amino acid change that takes place due to the 










1:117510670 T SCN1B ENSCAFG00000007129 1/5 A/T Gca/Aca -1 
1:119322126 T RGS9BP ENSCAFG00000007509 1/1 R/H cGc/cAc -1 
7:56104802 T ASXL3 ENSCAFG00000017980 10/11 T/N aCt/aAt -1 
7:56104802 T ASXL3 ENSCAFG00000017980 4/5 T/N aCt/aAt -1 
7:57946958 C TTR ENSCAFG00000018046 1/4 S/G Agc/Ggc -1 
8:4065167 A LRRC16B ENSCAFG00000011712 16/40 A/T Gcc/Acc 1 
14:26883912 A - ENSCAFG00000009915 4/8 A/T Gcc/Acc 1 
14:36176692 C - ENSCAFG00000009635 4/6 W/R Tgg/Cgg 1 
14:36176713 C - ENSCAFG00000009635 5/6 C/R Tgt/Cgt 1 
27:31190558 C PTPRO ENSCAFG00000012789 2/27 N/S aAc/aGc -1 
34:32184727 C ZBBX ENSCAFG00000014517 18/20 K/R aAa/aGa -1 
34:32184727 C ZBBX ENSCAFG00000014517 16/17 K/R aAa/aGa -1 
X:19788059 A - ENSCAFG00000013408 6/7 T/N aCc/aAc 1 
X:19789132 T - ENSCAFG00000013408 7/7 T/S Acc/Tcc 1 
X:19789321 A - ENSCAFG00000013408 7/7 A/T Gcc/Acc 1 
X:19789651 G - ENSCAFG00000013408 7/7 L/V Ctt/Gtt 1 




Table IV.7. Biological significance and function of the 33 genes with detected 








Description  Function 
Biological 
significance 





Rat, Zebrafish  
Dedicator of 
cytokinesis 8 
Encodes a member of DOCK180 
family guanine nucleotide 
exchange factors that interact 
with Rho GTPases & take part in 













Asc-type amino acid transporter - 
Mediates high-affinity transport of 
D-seine and several other neutral 
amino acids  
Visceral fat in 
women 











Encodes protein that regulates G 
protein-coupled receptor 
signaling in photo-transduction. 
Bovine and mouse studies show 
the protein to be expressed only 







or PERRS)  










Methylation of TSHZ3 promoter is 
present in breast/prostrate 
cancer. Regulation of myogenic 
differentiation in the ureter in 
























Encodes protein that localizes to 
the mitochondria and maybe 
















Single-pass type II membrane 
protein (member of transferrin 
receptor-like family) that mediates 
cellular uptake of transferrin-






osis type III 






Encodes member of kinesin 
superfamily (ATP-dependent 
microtubule-based motor proteins 
involved in intracellular transport 

















Involved in stress-related DNA 



















regulator 3  
Belongs to family of epigenetic 












Frog, Rice A. 
thaliana, Fruit 



















One of the 3 prealbumin carrier 
proteins that transport thyroid 
hormones in the plasma and 
CSF, also retinol in plasma. Also 
found on cartilage surfaces 
(extracellular matrix 
organization). More than 80 
mutations reported - mostly 
related to amyloid deposition 
disorders affecting peripheral 
nerves and/or heart.Associated 
with aging (loss over time) leads 




































Candidate onco-fetal gene 
(expressed in embryos/fetuses 
that should get down-regulated/ 
undetectable in adult tissue, but 
are found in tumors). Also in 



















aarF  domain 
containing 
kinase 1 











Encodes for beta subunit of the 
adducin family that cross-links 
actin filaments with spectrin at 
cytoskeletal membrane. Primarily 





















Encodes the protein core of 
plasma proteoglycan containing 
chondroitin and heparan-sulfate 
chains. Function unknown. 
Suspected to be similar to 
thyropin-type cysteine protease-


















spanning protein that contains a 
RING-H2 finger. Located in the 
endoplasmic reticulum. Has 
ubiquitin ligase activity. Possibly 
responsible for degradation of 




























Function unknown. NA 













factor 1 alpha 
1 
Encodes an isoform of the alpha 
subunit of the elongation factor-1 
complex that enzymatically 
delivers amino-acyl tRNAs to the 
ribosome during translation. 
Expressed in the brain, placenta, 























Part of the pro-oncogenic protein 
disulfide isomerase (PDI) family - 


























DnaJ heat shock superfamily 
Pancreatic 
cancer 
























Encodes member of M14 family 
of Metallo-carboxypeptidases. 
Peripheral membrane protein 
cleaves C-terminal amino acid 
residues & is involved in 
biosynthesis of peptide hormones 
& neurotransmitters like insulin. 
Functions as a neurotrophic 
factor promoting neuronal 
survival and/or sorting receptor 


























An early response estrogen-
responsive gene in the estrogen 
receptor-regulated pathway. 
Believed to play an important role 
in hormone-responsive tissues 



























Expressed primarily in the brain, 
this gene is believed to encode a 
scaffolding protein that is involved 
in organizing the presynaptic 






















In humans, this gene is upstream 
of, and in head-to-head 
orientation with the gene for 
mitochondrial ribosomal protein 
L34. Predicted protein has 
alpha/beta hydrolase fold and 













Encodes a member of the folate 
receptor family. Proteins of this 
family have high sequence 
homology with each other, and 
have a high affinity for folic acid 
and its derivatives, mediating the 
delivery of 5-
methyltetrahydrofolate to the 










in mice.  








Encodes a cytoskeletal protein 
that is required for organizing the 
actin cytoskeleton - a component 
of actin containing microfilaments 
that is involved in the control of 


























Encodes a membrane-associated 
protein that is part of the ATP-
binding cassette superfamily 
(transport various molecules 
across extra- and intra-cellular 
membranes). This protein is also 
a part of the MRP subfamily that 
is involved in multi-drug 
resistance. The protein forms 
ATP-sensitive potassium 
channels in cardiac, skeletal, and 



















paralysis.   









Encodes member of R3 subtype 
family of receptor-type protein 
tyrosine phosphatase. Localized 
to apical surface of polarized cells 
and may have tissue specific 
functions through activation of 
Src family kinases. Multiple 
isoform-specific & tissue-specific 
functions (regulation of osteoclast 
production & activity, inhibition of 






































Encodes a member of the SNF 
subfamily of helicase proteins 
that plays a critical role in 
restoration of heterochromatin 
organization and propagation of 
epigenetic patterns after DNA 












Function unknown. NA 








Structurally similar to a related 
gene on Y chromosome. 
Encodes a member of the 
krueppel C2H2-type zinc-finger 
protein family. Full-length protein 
product contains an acidic 
transcriptional activation domain, 
a nuclear localization sequence & 
DNA binding domain (13 C2H2-
type zinc fingers). Mice studies 
suggest role in stem cell self-
renewal, not growth & 
differentiation of stem cell 
progeny.  
Several types 





















Encodes a member of the 
peptidase C19 family that is 










Table IV.8. Human LSS candidate genes and their location in the canine genome  
 
* Strong association found in human lumbar spinal stenosis studies. 
 
Legend 
COL (x) A (y): Collagen Type (x), Alpha (y) CF: Canis familiaris chromosome 
number 
VDR: Vitamin D Receptor MMP-3: Matrix Metallopeptidase 3 
OA: Osteoarthritis DDD: Degenerative Disc Disease 
EDS: Ehlers-Danlos syndrome OI: Osteogenesis imperfecta 
OPLL: Ossification of Posterior Longitudinal 
Ligament 













COL1A1 17 CF 9 LSS 
COL1A2 7 CF 14 LSS, OI, EDS 
COL2A1 12 CF 27 OA, LSS 
COL9A1 6  CF 12 OA, LSS 
COL9A2* 1 CF 15 OA, LSS, DDD 
COL9A3 20 CF 24 OA, LSS, DDD 
COL11A1 1 CF 6 OA, LSS 
COL11A2* 6 CF 12 OA, LSS, DDD, OPLL 
VDR 12 CF 5 DDD, LSS 




CHAPTER V. OVERALL SUMMARY AND CONCLUSIONS 
 
Lumbosacral stenosis (LS) in large breed dogs is a major debilitating condition that can 
often lead to compression, irritation and stretching injury of nerves and their blood vessels 
that can then lead to clinical conditions.  The most common outward signs of LS on 
physical examination in dogs include a painful reaction to palpation of the lower back region 
or elevation of the tail, abnormal tail carriage, reluctance to sit, reluctance to jump up into 
a car or truck, refusal to climb stairs or other obstacles, and reluctance to assume 
positions that require hyperextension of the lower back such as standing upright on the 
hind limbs or jumping over obstacles 16. Working dogs differ from most companion dogs in 
that they are bred and trained to be stoic and are highly motivated to do their job.  They 
often mask clinical signs of pain in the early stages. Thus, LS in working dogs, especially 
in high-drive breeds like Labrador retrievers, often does not become apparent until the 
dog develops an irreversible functional deficit. By the time this happens, the likelihood of 
return to full active duty is significantly decreased. Early detection of the likelihood of this 
disease occurring and implementation of necessary rehabilitative treatments is critical for 
minimizing loss of man-hours, financial investment, and mission readiness for teams that 
depend on working dogs. The current standard for detection of LS usually involves 
expensive radiological imaging investigations like computed tomography (CT) and 
magnetic resonance imaging (MRI). These methods are expensive and lengthy, not really 
feasible at the time of procurement of dogs for training intention. Basic radiographs are 
used instead that can rule out musculoskeletal diseases like canine hip dysplasia and 
canine elbow dysplasia, but cannot detect lumbosacral joint abnormalities like LS. This 
warrants the development of a possible genetic biomarker for the disease that can 
potentially inexpensively help identify the predisposition of LS well before symptoms 
become too severe. The goal is to identify the structural risk factor before the dog starts 
showing irreversible clinical signs and is forced to retire – so early intervention would 
allow for implementations of modified training protocols or re-designed working tasks 
aiming for minimizing loss of muscle mass and developing of compensatory gait 




also assist international working dog breeder associations in their efforts to produce 
higher quality dogs.  
 
At the time of inception for this project and on its completion, no published information 
could be found describing the genetic risk factors for LS in the Labrador retrievers. 
Studies have stated that Labrador retrievers are at high-risk for LS, but the exact reasons 
are mostly unknown lacking scientific evidence.  The purpose of this project was to 
phenotype and genotype LS in Labrador retrievers. In this project, we focused on young 
working Labrador retrievers to detect genetic predisposition without the interferance of 
aging as a co-factor. We also selected MWD housed at the same base to rule out other 
environmental variables.  
 
The most significant finding from the first study of this project was the development of the 
novel CT measurement of fat area ratio (FAR) to phenotypically quantify LS allowing 
robust statistical analyses to strengthen research findings (Chapter III). This FAR 
measurement displayed a strong association with the qualitative assessment of LS (as 
made by a veterinary radiologist, the current standard). The other measurement i.e. canal 
area ratio or CAR was not so successful in agreement with CT qualitative diagnosis of LS. 
Possible reason for this observation could be due to the fact that just a subjectively 
“narrow” canal (as estimated by the ratio of the canal area over vertebral body area) 
would not be assigned by the radiologist as LS positive without the presence of other 
characteristic signs of LS – loss of epidural fat being one such trait. Since FAR is a 
measure of this loss of epidural fat in the vertebral canal, this could be the reason behind 
FAR having good agreement with qualitative assessment of LS as made by a licensed 
veterinary radiologist. Because the genotyping study (Chapter IV) was a prospective 
study, the study design allowed for CT scans to include images of 8 vertebral locations 
that included both part of the lumbar spinal canal (L4) as well as the “standard” 
lumbosacral spine (L5 – S1) recorded in the clinical setting. The two additional location 




be sequenced, even though the measurements at these two locations could not be 
validated in study 1 (chapter III).  
 
Another significant finding from this project came from the second study. We were able to 
identify 3 new possible “candidate genes” – TTR, FOLR2 and USP9X. Even though there 
are no genetic studies that can explain whether these 3 genes are true candidate genes, 
few non-genetic studies have hinted at possible associations. Transthyretin (TTR) has 
been associated with Senile Systemic Amyloidosis or SSA – a condition often appearing 
simultaneously with LSS in humans. Folate receptor 2 or FOLR2 has also been found in 
macrophages in the synovial lining of individuals affected by osteoarthritis – a condition 
also found to be present in individuals already affected by LSS. And lastly, Ubiquitin 
Specific Peptidase 9 X-linked or USP9X has differential expression between males and 
females, and the difference in incidence rate of LS in males and females could have a 
connection with the expression patterns of this gene. The connection of LS with these 
genes is spurious at best at the present time; so more rigorous investigations are 
necessary where robust statistical analyses can be done before any claims of association 
can be made. The other 30 genes also identified as carrying exonic variants differing 
between LS positive and LS negative groups could also have significance, even though 
none could be found in the present date (limited by the annotations of genes uploaded by 
different research groups working on different subjects). The study also looked at human 
LSS candidate genes, however no significant variants were detected. However, it is too 
early to rule out these candidate genes, further investigations are needed to either 
confirm their validity as canine LS candidate genes before any claims can be made that 
canine LS and human LSS do not share the same disease pathology i.e. same candidate 
genes.  
 
This was an exploratory study of LS in a pre-disposed and high-risk breed 130. However 
most studies of LS in dogs lean heavily towards German shepherds (the most commonly 
affected breed according to studies reported), more studies are required investigating LS 




in LS in other breeds (not just Labrador retrievers) need to be undertaken – that could tell 
us if they are breed specific factors or more universal. These findings could also very well 
be translated into the human lumbar spinal stenosis problem that closely resembles 





CHAPTER VI. RECOMMENDATIONS 
A genetic test for detecting risk factors of LS in working dogs could help reduce the risk 
of early retirement in these valued animals.   Lumbosacral stenosis is not detectable 
with routine screening methods currently used at the time of military working dog 
procurement.  A genetic test that could be successfully used at the time of procurement 
could potentially save the military millions of dollars.  In addition, this genetic test could 
help owners, breeders, and trainers of other at-risk working dogs detect the problem 
earlier and implement preventative measures.  Our study identified promising candidate 
genes that warrant further study.  In particular, transthyretin (TTR) may be a marker for 
premature degeneration of connective and ligamentous tissues.  Future studies of blood 
and tissue samples from clinically affected dogs would be needed to explore the true 
nature of the relationship between TTR and LS.  Small sample sizes are not ideal for 
genome wide association studies (GWAS), but GWAS can be useful in future 
association studies if the sample size could be larger. So a GWAS for LS in a larger 
sample of Labrador retrievers could yield interesting results.  
 
Improved methods for quantitative deep phenotyping of LS in dogs could be helpful for 
supporting development of these genetic tests.  In the current study, fat area ratio (FAR) 
was introduced as a novel CT measurement that can quantitatively characterize 
lumbosacral stenosis (LS) in Labrador retrievers for research purposes and possibly 
also in other breeds of dogs. In order to develop more definitive threshold values, 
further studies are needed in a larger sample of Labrador retrievers as well as other at-
risk breeds. Further analysis is also needed to compare the ratio measurements with 
the absolute measurements in this study. Canal area ratio or CAR did not have a 
significant association with qualitative LS in our sample population of dogs, however 
further studies testing the relationship between CAR and FAR may be helpful. These 
two measures detect different structural phenotypic traits and may also be 
complementary.  Canal area ratio primarily quantifies bony canal narrowing and FAR 
detects narrowing due to a combination of bony and soft tissue encroachment (i.e. the 




condition). Consistent with previous studies, low back pain status (LBP) was not 
significantly associated with an overall qualitative diagnosis of LS.  However, when 
multi-level stenosis (i.e. stenosis at 2 or more vertebral levels) was examined as a 
separate factor, subjective evidence of a possible association between multi-level 
stenosis and LBP was observed. Statistically significant associations were not detected 
due to small sample size.   Future studies should explore the interactions among risk of 
early retirement due to LS and all possible co-variates such as LBP status, number of 
levels of stenosis, age, gender, working status, and body weight. 
 
Improved methods for collecting, storing and analyzing genetic material are also needed 
to support development of genetic screening tests for LS in dogs.   Multiple studies have 
reported several different protocols for extraction of DNA from biological samples 
(including blood) on FTA™ cards. After several trials using different commercially 
available protocols, the GenTegra platform (combination of GenTegra’s GenSolve kit 
and QIAGEN’s blood purification kit) had the best yield of DNA for dogs in our sample – 
both quality and quantity of the extracted DNA was sufficient for downstream 
sequencing reactions. Thus, use of FTA cards was found to be a feasible method for 
collection and storage of blood samples, and extraction of DNA for genetic testing in 
military working dogs.   This technique could therefore be used in future studies of 
military working dogs deployed in locations far away from medical facilities and/or 
sources of refrigeration. 
 
An improved understanding of the progression of LS in dogs is also needed.  There are 
two distinct etiologies of LS in dogs – congenital and acquired. Degenerative LS falls 
into the acquired category, while idiopathic LS is a rare but congenital type of LS. The 
primary aim would be to understand the difference between idiopathic and degenerative 
LS – whether different genetic mechanisms are responsible for the different types of LS 
or whether they share the same/similar pathophysiological mechanisms. One possible 
future study could be to follow the outcomes of the same 40 dogs in this study over the 




LS positive over time and/or whether the LS positive dogs develop worsening of their 
condition and/or experience early retirement. A longitudinal study starting with a large 
number of young Labrador retrievers and tracking their growth, as well as the 
occurrence and/or progression of LS in them over the years could also be informative 
for our attempt at understanding the mechanisms underlying LS in dogs. This study 
design will also allow for identifying and understanding the distinction between 
idiopathic LS and degenerative LS. This type of study design would also allow for 
studying the relationship between working tasks performed by the dogs and the effect 
they might have on the lumbosacral spine of the dogs.  
 
More studies also need to be done to develop more sensitive tests for early detection 
and more accurate localization of lower back pain in working dogs. Current standard 
clinical tests such as palpation of low back region of the spine and recording the dog’s 
reaction to the stimuli are too insensitive for early detection of LS in stoic, high-drive 
working dogs. Breed specific phenotypic traits involving the lumbosacral and the 
sacroiliac joints also warrant further investigations as possible sources of LBP and early 
retirement in working dogs, i.e. the dog could be displaying signs of pain due to these 
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Appendix I:  Protocol used for DNA extraction from FTA cards  
GenTegra™ GenSolve™ DNA recovery Kit (GenTegra LLC., Pleasanton, 
CA) 
Kit Contents  
1. Recovery Solution A; 0.2 ml, 4 each  
2. 1% LiDS Solution; 66 ml, 1 bottle  
3. Protease solution; 2.5 ml, 1 vial  
4. Recovery Solution B; 2.5 ml, 1 vial  
5. User Guide  
Storage 
Protease should be stored at 2-8 °C. All other components can be stored at either room 
temperature or 2-8 °C. After re-suspension and addition of Protease, Recovery Solution 
A should be used within 2-3 hours for maximum DNA yield.  
Additional Equipment and Materials required 
o Incubator/Shaker  
o GenTegra Spin Basket/Tube Assembly (GenTegra #GVSPIN250)  
o Ethanol, 100%  
o QIAGEN QIAamp DNA Blood Mini Kit (50 preps, QIAGEN #51104)  
o QIAGEN 2.0 ml collection tubes (QIAGEN #19201)  
o Millipore Microcon MRCF0R100 (optional)  
o Microfuge Tubes, 1.7 ml and 2.0 ml  
o P200 and P1000 pipettes, pipette tips  





Stage	  1:	  DNA	  recovery	  
1. Pre-heat Incubator/Shaker to 65°C. 
2. To the bottle of Solution A, add 1% LiDS according to the volumes in Table 1. 
 
Table 1. Volume of 1% LiDS and Protease used to add to Solution A 
 
Volume of 1% LiDS Volume of Protease 
16 ml 535 µL 
 
3. Vortex briefly to mix Solution A bottle and LiDS solution.  
4. Add Protease into the vial of Solution A from Step 2 according to the volumes 
described in Table 1 and vortex briefly.  
5. Punch element(s) into one 2 ml microtube for each unique sample. 
6. Add 620 µL of Recovery Solution A/Protease mix. 
7. Place the tube in the Incubator/Shaker pre-heated to 65 °C. Vortex ~1 minute at 
1,400 rpm and inspect to make sure that each element is completely submerged 
in the solution; repeat until all elements are submerged. Continue vortexing for 
one hour. It is important to vortex at 1,400 rpm for maximum DNA recovery. If 
speed <1,400 rpm, vortex for 2 hours, speed < 700 rpm is not recommended. 
8. Centrifuge at 16,300 x g for 0.5 minutes to collect liquid off cap. 
9. Add 20 µL of Recovery Solution B to a new microcentrifuge tube and insert a 
spin basket. Transfer the solution from step 7 into the Spin Basket making sure 
to transfer along the element(s) by scooping it with pipette tip. 
10. Centrifuge at 16,300 x g for two minutes. 
11. Discard Spin Basket and element. 
12. Pulse vortex each microtube. 




Stage	  2:	  DNA	  Purification	  
1. Add 600 µL of 100% Ethanol to each microtube containing recovered DNA. 
2. Pulse-vortex each sample. Centrifuge briefly. 
3. Load 600 µL of the sample onto a spin column/collection tube. Close the cap and 
centrifuge at 6,000 x g for 1 minute. Place the spin column in a new 2 ml 
collection tube and discard the tube containing the filtrate. 
4. Repeat step 3 until the entire sample has been applied into the spin column. 
5. Add 500 µL of AW1 Buffer onto the spin column and centrifuge at 6,000 x g for 1 
minute. Discard the collection tube containing the filtrate and place the spin 
column in a new 2 ml collection tube. 
6. Add 500 µL of AW2 Buffer onto the spin column and centrifuge at 16,300 x g for 
4 minutes. Discard the collection tube containing the filtrate and place the spin 
column in a new 2 ml collection tube. 
7. Centrifuge at 16,300 x g for 1.5 minutes. 
8. Place the spin column in a new 1.7 ml tube. 
9. Elute the DNA sample by adding 200 µL of AE Buffer to spin column. Incubate 
the sample at room temperature for 5 minutes and centrifuge at 6000 x g for 1 
minute. 





Appendix II:  Description of an unexpected qualitative phenotypic trait observed 
in this sample of Labrador retrievers, i.e. “a reverse trapezoid vertebral canal”. 
Previous studies have reported that the shape of the lumbosacral canal becomes 
progressively semi-circular or crescent shaped as it transitions from the cranial to the 
caudal end of the canal 112, with the cross-sectional area of the canal is at its greatest at 
mid-lumbar level and gets progressively narrower both cranially and caudally to that. 
Conventional belief is that the canal begins wider at the lumbar level and then 
progressively narrows as the canal transitions to the sacrum.  
 
However, during the construction of bar-graphs to represent mean canal area ratio 
(CAR) and mean fat area ratio (FAR) values of LS negative and LS positive dogs at 
each of the 6 vertebral locations (L5Cd – S1Cr) in chapter III, an interesting observation 
was made with regards to the shape and size of the vertebral canal as it transitions from 
the cranial end to the caudal end of the body. At each vertebral level, the cranial end 
was narrower than the caudal end. This “reverse trapezoid” pattern of the vertebral 
canal was not found to be reported in any previously published literature.  
 
This structural characteristic of the lumbosacral spine was observed in all dogs in both 
the studies (1 and 2) of this project for both the ratio measurements: mean canal area 
ratio or CAR (Figure A.1 and A.2); and mean fat area ratio or FAR (Figure A.3 and A.4). 
Since vertebral body measurements were used to construct the ratios, the analyses 
were also repeated with the absolute values to test whether the vertebral body 
dimensions could be a source of variation. However, this trend was observed in both 
sets of absolute values – mean canal area or CA (Figure A.5 and A.6); and mean fat 
area or FA (Figure A.7 and A.8).  
 
This trait appears to be more prominent from L5 cranial to S1 cranial locations. It is 
important to note that all dogs in our project were of a single breed i.e. Labrador 
retrievers. So this trait could be specific to this breed alone, or it could be a canine 




assign this trait to this specific breed. Further studies are needed in larger sample of 
Labrador retrievers (to validate this observation) as well as other breeds of dogs to 









Figure A.1. Mean canal area ratios (CARs) in study 1 
























Figure A.2. Mean canal area ratios (CARs) in study 2  


























Figure A.3. Mean fat area ratios (FARs) in study 1  


























Figure A.4. Mean fat area ratios (FARs) in study 2  
(N=40 at L4Cd – S1Cr) 
 
 	  

























Figure A.5. Mean canal areas (CAs) in study 1 




























Figure A.6. Mean canal areas (CAs) in study 2  





























Figure A.7. Mean fat areas (FAs) in study 1 



























Figure A.8. Mean fat areas (FAs) in study 2  
(N=40 at L4Cd – S1Cr) 
 
 	  





















Appendix III:  Logistic regression analysis of the association between FAR and 
qualitative LS status in the 40 dogs recruited for the second study (chapter IV) 
Logistic regression analysis from study 1 was repeated in 40 dogs of the second study 
(see chapter III). The association between fat area ratio (FAR) values and the 
qualitative assessment of LS was statistically significant (p<0.0001) at only one 
vertebral location – L6 cranial (Figure A.9). We were able to identify that age is a 
covariant in this model, i.e. FAR values have better correspondence with qualitative LS 
status with increasing age (Figure A.10). Study 1 was able to identify that older dogs 
have a higher incidence of qualitative LS. However it is important to note that older dogs 
are at a higher risk of acquiring degenerative LS, a disease process that could be 
separate from idiopathic LS (type of LS probably observed in study 2 sample of young 
Labrador retrievers). This warrants further analysis where distinction between idiopathic 









Figure A.9. Logistic regression of FAR v qualitative LS at L6Cr 
 
  






















































Appendix IV:  Proposed explanations for clinical low back pain observed in dogs 
from both studies. 
In study 1, there were 14 LS positive dogs. Eight of these 14 dogs were low back pain 
(LBP) negative. The remaining 6 dogs were positive for both LS and LBP. Five out of 
these 6 dogs (83.33%) were stenotic at more than one vertebral level, while the 
remaining 1 dog was LS positive at only one vertebral location. There were 3 (out of 11) 
dogs that were LBP positive despite being LS negative. This contradiction can be 
explained by the presence of one or more of the following conditions that can cause 
LBP in the lumbosacral junction (besides LS) in all 3 dogs: sacroiliac joint disease 132, 
foraminal stenosis 133, and Schmorl’s nodes 134. 
 
In study 2 there were 33 LS positive dogs. Fifteen out of these 33 were LBP negative 
(possible causes explained in previous chapters). The remaining 18 were positive for 
both LS and LBP. Fourteen of these 18 dogs (77.78%) were stenotic at more than one 
vertebral level, while the remaining 4 were LS positive at only a single location. There 
were 6 (out of 7) dogs that were LBP positive despite being LS negative. Again the 
reason for this discrepancy could be due to other clinical conditions that can affect the 
lumbosacral spine of large breed dogs. 
 
Out of the 8 dogs selected for exome sequencing, the LS positive group comprised of 2 
LBP positive dogs and 2 LBP negative dogs. It is interesting to note that the 2 LBP 
negative LS positive dogs had stenosis at only 1 vertebral level, while each of the 2 LBP 
positive LS positive dogs were stenotic at more than 2 levels (3 and 4 levels). On the 
other hand the LS negative group had only 1 dog that was negative for both LS and 
LBP. The other 3 dogs showed signs of pain, though only one of them had stenosis at a 
single level. The pain displayed by these relatively asymptomatic dogs could be due to 
other reasons (previously described) besides LS. 
 
So in both studies, majority (83% in study 1, and 78% in study 2) of the LS positive dogs 




observation could be explained by the theory that compression of the cauda equina 
nerves at 2 or more locations causes increased disruption of electrical signals and 
arterial blood supply 65 62. Future studies are necessary to understand the true nature of 
the relationship between LS and LBP, especially the significance of LS at multiple 






Appendix V:  Analysis of covariance and multivariate logistic regression tests for 
effects of covariates on comparisons between FAR and LS status in dogs from 
both studies.  
Analyses of covariance (ANCOVA) were done using PROC GLM procedure of statistical 
software SAS on combined datasets of studies 1 and 2 (N = 65). The ANCOVA tested 
whether regression of the quantitative measurement FAR on age (covariate) differed 
between the two groups (LS positive and LS negative) at the 6 common vertebral 
locations: L5Cd, L6Cr, L6Cd, L7Cr, L7Cd and S1Cr. The terms in the model are: main 
effect of group, main effect of age and the interaction of the group and age. The 
significant interaction of age and group in the ANCOVA would be an indicator of the 
different slopes between the two groups (LS positive and LS negative). The p-values for 
ANCOVA analyses on the combined dataset were significant for the main effect of 
group (qualitative diagnosis of LS) at all locations except L5Cd: L6Cr (p<0.0001), L6Cd 
(p=0.0097), L7Cr (p=0.0010), L7Cd (p<0.0001) and S1Cr (p<0.0001). This also serves 
as a verification of earlier results of study 1 and L6Cr results in study 2. The p-value 
was also significant for the main effect of age at L7Cr (p=0.0058). However, the 
interaction term (age and qualitative LS) was not significant at any of the 6 locations.  
 
In addition the multivariate logistic regression was done on this combined dataset, 
where variables such as age, weight, and sex were added besides the LS diagnosis to 
see if any of them or their interactions can predict FAR. The p-values were significant 
for the main effect of LS at 4 of the 6 vertebral locations: L5Cd (p=0.0189), L6 Cr 
(p<0.0001), L7Cr (p=0.0018) and S1Cr (p=0.0033). Interaction of age with LS status 
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